Degenerative diseases of the nervous system

G6_NEURODEG

neurodegenerative disease: A disorder of the central nervous system characterized by gradual and progressive loss of neural tissue and neurologic function.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints G6_ALZHEIMER G6_ATROPHCIRCUM G6_DEGENSEN G6_ALCODEGEN G6_DEGENOTH	19216
6. Filter based on genotype QC (FinnGen only)	18671

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF12

NAME	G6_NEURODEG
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_ALZHEIMER\|G6_ATROPHCIRCUM\|G6_DEGENSEN\|G6_ALCODEGEN\|G6_DEGENOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Degenerative diseases of the nervous system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	18671	8694	9977
Unadjusted period prevalence (%)	3.88	3.08	4.57
Median age at first event (years)	79.96	80.25	79.71

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17345: Matched controls
127382

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

94.5

313.0

216

P20

ICPC

Memory disturbance

6.8

307.7

8074

14369

N05AH03

ATC

olanzapine; systemic

4.0

307.7

1082

2072

AA1AD

NOMESCO Finland

CT of head and brain

1.9

307.7

6388

29557

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.9

307.7

2330

6528

F03

ICD-10 Finland

Unspecified dementia

7.3

307.7

3195

3835

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

74.3

307.7

5318

754

N06DX01

ATC

memantine; oral

48.2

307.7

9707

3273

R41.0

ICD-10 Finland

Disorientation, unspecified

4.0

307.7

1302

2526

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

157.2

307.7

816

SPAT1053

SPAT

Memory test

3.5

307.7

6311

17813

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.9

307.7

1927

3919

N06DA04

ATC

galantamine; oral

15.2

307.7

2134

1163

P70

ICPC

Dementia

16.5

307.7

2091

1050

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

193.1

307.7

5124

276

F05.1

ICD-10 Finland

Delirium superimposed on dementia

13.4

307.7

512

288

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.0

307.7

3101

8543

N05AH04

ATC

quetiapine; oral

4.3

307.7

4167

8796

G30

ICD-10 Finland

Alzheimer disease

52.5

307.7

1249

188

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

42.3

307.7

1293

242

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

102.3

307.7

592

F0019, G301,

ICD-10 Finland

5447.3

307.7

719

N06AX11

ATC

mirtazapine; oral

2.0

307.7

6057

27468

G30.0

ICD-10 Finland

Alzheimer disease with early onset

380.3

307.7

1160

G30.1

ICD-10 Finland

Alzheimer disease with late onset

95.1

307.7

9136

1474

WYA20

NOMESCO Finland

Home visit

6.7

307.7

863

990

F009, G309,

ICD-10 Finland

1574.6

307.7

433

N05BA04

ATC

oxazepam; oral

2.3

307.7

5511

21191

N06DA03

ATC

rivastigmine; oral, transdermal

24.2

307.7

4738

1948

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

307.7

4084

15591

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

307.7

7399

32855

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

307.7

5177

21517

R53

ICD-10 Finland

Malaise and fatigue

2.3

307.7

5461

21267

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

44.4

307.7

4045

866

F06.7

ICD-10 Finland

Mild cognitive disorder

4.8

307.7

1412

2332

A28

ICPC

Limited function/disability NOS

3.0

307.7

6331

20627

N05AX08

ATC

risperidone; systemic

10.0

307.7

4910

4832

SPAT1216

SPAT

Assessment of functional ability

2.3

307.7

4576

16985

G31.0

ICD-10 Finland

Circumscribed brain atrophy

126.3

307.7

566

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

117.0

307.7

313

N06DA02

ATC

donepezil; oral

34.0

307.7

7306

2669

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.6

307.7

5128

7624

SPAT1234

SPAT

Support of social functional capacity

3.3

307.7

1856

4484

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

26.3

307.7

2444

789

N03AG01

ATC

valproic acid; systemic, rectal

3.9

307.7

1279

2559

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

37.8

307.7

534

107

G30.8

ICD-10 Finland

Other Alzheimer disease

68.9

307.7

2939

376

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

33.7

307.7

756

172

R41.3

ICD-10 Finland

Other amnesia

5.6

307.7

1407

1966

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

144.7

307.7

718

TAB00

NOMESCO Finland

Lumbar puncture

5.4

307.7

1084

1548

XA800

NOMESCO Finland

Neuropsychological investigation

4.6

307.2

832

1371

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

286.5

3957

16144

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.9

284.5

1585

4292

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

282.2

6466

31219

SPAT1254

SPAT

Administration of medicine

2.1

277.5

3630

14493

N05AD01

ATC

haloperidol; systemic

3.6

256.5

990

2134

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

51.7

252.5

188

A06AD11

ATC

lactulose; oral

1.9

249.2

4075

17520

N06AB10

ATC

escitalopram; oral

2.2

234.9

2577

9557

L28

ICPC

Limited function/disability (L)

1.9

234.7

4368

19533

N02AA05

ATC

oxycodone; systemic

1.9

231.2

4256

18952

F001, G301,

ICD-10 Finland

83.1

224.6

157

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

4.8

223.8

574

900

A04

ICPC

Weakness/tiredness general

2.0

219.4

3118

12705

N06AX26

ATC

vortioxetine; oral

3.2

217.6

991

2374

N05BA06

ATC

lorazepam; systemic, sublingual

2.7

217.5

1305

3662

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

70.4

213.3

152

F0009, G300,

ICD-10 Finland

+∞

208.8

226

S72.0

ICD-10 Finland

Fracture of neck of femur

2.6

202.7

1400

4217

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

197.4

1313

3880

F00

ICD-10 Finland

Dementia in Alzheimer disease

16.0

196.9

205

Z75.5

ICD-10 Finland

Holiday relief care

5.6

193.5

423

571

S01.0

ICD-10 Finland

Open wound of scalp

2.2

190.4

1810

6297

F05.9

ICD-10 Finland

Delirium, unspecified

3.4

183.3

738

1631

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.4

175.4

493

835

U04

ICPC

Incontinence urine

2.4

172.3

1415

4612

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

172.1

3152

13843

Z02.4

ICD-10 Finland

Examination for driving licence

0.5

171.6

2741

32520

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.9

166.8

917

2446

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

72.1

164.6

117

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

32.9

158.1

129

F0029, G308,

ICD-10 Finland

+∞

154.2

167

S06.0

ICD-10 Finland

Concussion

2.0

150.0

1923

7476

SPAT1101

SPAT

Orthostatic test

2.3

147.7

1272

4225

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

145.6

1002

3000

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

243.1

143.6

165

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

143.4

1157

3732

N06AB04

ATC

citalopram; systemic

1.7

140.8

3364

15842

R55

ICD-10 Finland

Syncope and collapse

1.8

139.6

2546

11097

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.6

138.8

900

2615

F0014, G301,

ICD-10 Finland

231.3

134.4

155

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

132.7

3176

14936

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.9

131.1

2068

8602

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

131.0

1331

4728

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.5

127.0

487

1040

SPAT1301

SPAT

No procedures

1.5

126.9

5733

31288

W19

ICD-10 Finland

Unspecified fall

1.9

126.3

1913

7847

N02BE01

ATC

paracetamol; systemic, rectal

1.6

121.4

14456

95846

SPAT1252

SPAT

Overall medication plan or its review

2.0

118.4

1587

6239

F21, ,

ICPC

4.4

118.3

331

558

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.7

117.1

682

1872

SPAT1229

SPAT

Assessment of need for aid

1.9

117.0

1849

7677

SPAT1360

SPAT

Extensive global examination

2.0

116.4

1466

5637

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

116.1

1364

5114

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

115.6

972

14430

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

114.4

2449

11126

N05AD03

ATC

melperone; systemic

3.6

109.1

394

807

AXX01, ,

SPAT

2.5

105.4

763

2335

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

31.7

104.4

130

Kela drug reimbursment

Malignant tumour

0.4

103.0

466

8918

A29

ICPC

General symptom/complaint other

1.7

102.3

2370

10974

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

102.0

2005

8871

34791

ICD-8 Finland

Other disease of brain, Atrophia cerebri

+∞

100.6

109

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

38.4

98.9

E86

ICD-10 Finland

Volume depletion

2.5

96.5

670

2009

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.6

96.0

607

1737

S70.0

ICD-10 Finland

Contusion of hip

2.2

95.9

884

3009

Z29

ICPC

Social problem NOS

3.2

93.4

403

929

N06AB06

ATC

sertraline; oral

1.9

92.6

1253

4927

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

30.7

90.3

R42

ICD-10 Finland

Dizziness and giddiness

1.5

88.7

4356

23805

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.6

87.5

320

661

H02AB02

ATC

dexamethasone; systemic

0.4

87.4

502

8696

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

87.1

1222

4860

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.1

84.9

258

465

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

84.9

930

3387

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

84.8

3310

33081

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.1

84.3

898

3236

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

84.0

2364

11449

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.8

83.9

211

325

AXX01

NOMESCO Finland

Memory assessment

11.2

82.4

103

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

82.3

1779

8054

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

81.9

1959

9106

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.2

80.2

345

794

SPAT1172

SPAT

Guidance concerning hydration

2.3

79.9

664

2160

N30.0

ICD-10 Finland

Acute cystitis

1.5

79.1

2672

13477

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

35.7

78.6

SPAT1139

SPAT

Nutrition survey

2.3

78.4

683

2268

P15

ICPC

Chronic alcohol abuse

3.3

77.9

330

752

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.8

77.9

264

517

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

4.1

77.5

239

436

SPAT1251

SPAT

Organisation of medication

2.1

76.7

789

2803

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

76.5

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.0

73.8

939

3608

Z2445

NOMESCO Finland

Psychologist

2.9

73.6

378

967

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.2

73.1

647

2162

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.5

72.9

519

1574

R1250

NOMESCO Finland

Evaluation of functional capability

2.9

72.2

367

934

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.7

71.9

2336

24368

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

9.7

71.0

F002, G308,

ICD-10 Finland

29.0

69.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

68.2

3049

16239

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.1

65.5

306

741

R33

ICD-10 Finland

Retention of urine

1.6

65.1

1882

9132

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

65.1

1236

5383

F0011, G301,

ICD-10 Finland

115.1

64.7

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

63.8

1281

5666

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

3.3

63.7

259

575

Z01.9

ICD-10 Finland

Special examination, unspecified

1.9

63.7

925

3712

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

12.6

61.8

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

61.7

2223

22837

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.4

59.7

452

1410

N07AA05, ,

ATC

130.9

59.6

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

30.1

58.6

SPAT1167

SPAT

Insertion of urinary catheter

1.9

58.0

791

3108

F22.0

ICD-10 Finland

Delusional disorder

3.1

57.6

265

636

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.6

57.6

1435

6709

WZC30

NOMESCO Finland

Teaching

0.6

57.3

1025

12320

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.9

57.1

791

3124

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.7

56.6

342

956

OAB76

NOMESCO Finland

General guidance on nutrition and food

11.9

56.6

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

56.0

1474

6983

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

8.4

55.7

J01CA08

ATC

pivmecillinam; oral

1.3

55.4

5401

32503

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

6.9

55.1

104

N28

ICPC

Limited function/disability (N)

2.6

54.9

343

976

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

25.2

54.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

54.4

2371

12513

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.3

54.3

457

1494

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.6

54.3

1549

16731

A04AA02

ATC

granisetron; systemic, transdermal

0.3

54.1

194

4181

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

5.1

53.5

126

183

Z28

ICPC

Limited function/disability (Z)

4.3

52.8

151

260

A10AB05

ATC

insulin aspart; parenteral

1.6

52.4

1223

5621

EB1VA, ,

NOMESCO Finland

0.5

52.0

405

6288

WX402

NOMESCO Finland

General anaesthesia

0.6

51.3

1205

13592

A03FA01

ATC

metoclopramide; systemic, rectal

0.7

51.1

1842

19015

F0024, G308,

ICD-10 Finland

+∞

50.7

C10AA07

ATC

rosuvastatin; oral

0.7

50.7

2909

27718

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

23.7

50.2

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.2

50.2

453

1526

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

49.7

1426

6886

S00.0

ICD-10 Finland

Superficial injury of scalp

2.2

49.5

441

1477

C10AA01

ATC

simvastatin; oral

1.3

48.8

8615

55683

M01AH05

ATC

etoricoxib; oral

0.8

48.5

5503

47750

R5110, ,

SPAT

1.6

48.3

1189

5535

N99

ICPC

Neurological disease other

3.0

47.8

234

583

C10AX09

ATC

ezetimibe; oral

0.6

47.8

1163

13036

G04CA02

ATC

tamsulosin; oral

1.3

47.8

5123

31084

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.9

47.4

115

172

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

22.6

47.2

J01EA01

ATC

trimethoprim; systemic

1.3

47.2

4221

24979

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.2

47.1

438

1494

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.7

46.7

120

189

ICB01, ,

SPAT

5.3

46.5

104

144

N29

ICPC

Neurological sympt/complt other

2.4

46.1

352

1103

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

84.0

46.0

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

45.9

1571

7880

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

45.5

378

1229

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

45.5

1457

15430

-2, ,

ICPC

3.7

45.4

160

323

F10.24

ICD-10 Finland

Alcohol depence active use

3.5

45.2

168

352

F05.8

ICD-10 Finland

Other delirium

3.2

44.9

196

456

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

44.8

1836

9547

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.3

44.7

103

2809

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

44.5

108

2859

W0A10

NOMESCO Finland

Mapping of psychosocial situation

7.5

44.4

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.8

44.4

148

287

SPAT1153

SPAT

Removal of sutures

0.8

44.2

3444

31506

G04CB01

ATC

finasteride; oral

1.4

44.1

2684

14968

SPAT1050

SPAT

Extensive neurological examination

2.2

43.9

391

1310

C03CA01

ATC

furosemide; systemic

1.3

43.7

7348

46980

Z03

ICPC

Housing/neighbourhood problem

3.8

43.2

145

283

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

42.9

5881

36679

N05CD07

ATC

temazepam; oral

1.4

42.9

2429

13380

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.5

42.9

290

859

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

42.7

2517

13958

LAITO, ,

NOMESCO Finland

9.7

42.6

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.0

42.5

503

1881

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.1

42.5

422

1478

P29

ICPC

Psychological sympt/compl other

2.0

42.3

463

1683

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

42.0

2395

13204

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

41.7

1046

4887

F0012, G301,

ICD-10 Finland

345.0

41.7

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

5.8

41.7

110

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

41.1

546

2126

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.0

40.9

500

1891

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

40.8

1494

15453

G72.8

ICD-10 Finland

Other specified myopathies

2.3

40.5

335

1088

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.1

40.5

400

1398

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

11.2

40.1

N03AX14

ATC

levetiracetam; systemic

2.1

39.3

410

1463

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

39.2

1035

4894

OAB43, ,

SPAT

0.3

39.1

121

2810

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

38.5

386

1357

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

38.3

1514

7808

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.7

38.3

223

613

F01.2

ICD-10 Finland

Subcortical vascular dementia

3.3

38.2

160

363

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

7.9

38.1

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

38.0

2438

13680

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

17.5

37.9

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

37.9

5013

31019

EB4VA, ,

NOMESCO Finland

0.4

37.6

200

3610

P05

ICPC

Senility, feeling/behaving old

3.3

37.4

154

346

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

37.3

1934

10479

F009, F03,

ICD-10 Finland

13.4

37.2

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

37.2

1354

6869

XX3DW

NOMESCO Finland

Time consuming IT work

0.6

37.0

730

8621

ZXY02

NOMESCO Finland

Neuropsychologist

5.8

36.9

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

4.0

36.9

113

206

N05AX12

ATC

aripiprazole; systemic

2.8

36.6

204

548

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

36.4

4618

28403

WZC00

NOMESCO Finland

Treatment plan or consultation

0.8

35.7

3239

29210

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.7

35.6

203

552

F00, F03,

ICD-10 Finland

8.5

35.6

WX212

NOMESCO Finland

Femoral plexus blockade

2.0

35.5

442

1683

WYA20, ,

SPAT

3.7

35.2

120

237

R11

ICD-10 Finland

Nausea and vomiting

1.5

35.1

1276

6469

A04AA01

ATC

ondansetron; systemic, rectal

0.5

34.8

399

5464

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.2

34.5

301

1001

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.4

34.0

236

3831

N17

ICPC

Vertigo/dizziness

1.4

33.8

2004

11089

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.9

33.8

109

207

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.9

33.6

171

437

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

33.4

1627

8712

R44.1

ICD-10 Finland

Visual hallucinations

3.4

33.3

133

293

L15

ICPC

Knee symptom/complaint

0.7

33.2

2000

19114

A10BK03

ATC

empagliflozin; oral

0.6

33.2

596

7211

Z51.5

ICD-10 Finland

Palliative care

1.4

33.1

1572

8376

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.8

33.1

111

217

R01AD58

ATC

fluticasone, combinations; nasal

0.7

33.0

1007

10817

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

52.8

32.8

SDA03

NOMESCO Finland

Periodontal treatment

0.8

32.4

2744

25020

E000001, ,

ATC

1.3

32.3

2545

14690

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.6

32.3

833

3916

F01.9

ICD-10 Finland

Vascular dementia, unspecified

1.9

32.2

427

1662

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.2

32.2

282

940

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.1

32.1

330

1173

L01BC06

ATC

capecitabine; oral

0.4

32.1

127

2612

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

32.0

682

3055

SPAT1284

SPAT

Extensive health certificate

2.1

31.9

342

1234

E51.2

ICD-10 Finland

Wernicke encephalopathy

11.5

31.8

Y94.1

ICD-10 Finland

Accident in connection with service housing

8.4

31.4

Y94.0

ICD-10 Finland

Accident at home

2.1

31.3

334

1203

F0022, G308,

ICD-10 Finland

+∞

31.3

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

31.2

4563

28422

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

31.0

3499

30840

AA1AD, ,

SPAT

5.0

30.8

110

F0021, G308,

ICD-10 Finland

256.1

30.8

SPAT1262

SPAT

Handing over of treatment supplies

1.3

30.5

2814

16580

F0013, G301,

ICD-10 Finland

+∞

30.4

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.4

30.4

141

2699

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.6

30.3

786

3698

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

30.0

146

2736

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.6

29.8

106

216

J01DB01

ATC

cefalexin; oral

1.2

29.8

11920

81879

N07BB01

ATC

disulfiram; oral

2.0

29.7

324

1177

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

29.6

2344

13521

N27

ICPC

Fear of neurological disease other

2.1

29.5

298

1052

H02AA02

ATC

fludrocortisone; oral

2.6

29.3

182

518

G47.3

ICD-10 Finland

Sleep apnoea

0.7

29.3

1515

14847

W06

ICD-10 Finland

Fall involving bed

2.5

29.3

193

566

SPAT1263

SPAT

Sampling

1.2

29.3

6064

39096

N05CF01

ATC

zopiclone; oral

1.2

29.2

5466

34884

R44.3

ICD-10 Finland

Hallucinations, unspecified

3.4

29.1

115

252

S18

ICPC

Laceration/cut

0.8

29.0

5477

45816

R27.0

ICD-10 Finland

Ataxia, unspecified

3.8

28.7

184

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

4.9

28.6

103

F02.80

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without additional symptoms

15.8

28.6

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

85.9

28.5

HA1RA, ,

SPAT

0.2

28.5

1562

A10AE04

ATC

insulin glargine; parenteral

1.4

28.3

1438

7747

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.3

28.1

234

764

P28

ICPC

Limited function/disability (P)

3.5

28.0

106

226

D12

ICPC

Constipation

1.6

27.9

617

2791

JN4AD

NOMESCO Finland

Body CT examination

0.7

27.9

842

9081

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.0

27.6

134

334

R01AD12

ATC

fluticasone furoate; nasal

0.7

27.6

1713

16342

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

27.3

2438

14284

F10.74

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol otherwise permanently impaired intelligence

15.2

27.2

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.3

26.9

1640

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.6

26.9

200

TQW40, ,

SPAT

0.5

26.8

334

4462

N06AX16

ATC

venlafaxine; oral

1.4

26.7

1169

6131

F02.09

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

51.6

26.7

E0000UV, ,

ATC

1.2

26.7

5538

35624

F06.0

ICD-10 Finland

Organic hallucinosis

4.7

26.6

104

J01MA02

ATC

ciprofloxacin; systemic

1.2

26.6

6305

41062

S01.8

ICD-10 Finland

Open wound of other parts of head

2.2

26.5

238

803

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.7

26.4

1645

15695

F10.8

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Other mental and behavioural disorders

8.2

26.2

T03

ICPC

Loss of appetite

3.9

26.2

156

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.7

26.0

1219

12152

R54

ICD-10 Finland

Senility

2.7

26.0

146

395

R26.0

ICD-10 Finland

Ataxic gait

4.3

25.9

125

Z72.1

ICD-10 Finland

Alcohol use

2.8

25.9

136

355

Z60.8

ICD-10 Finland

Other problems related to social environment

4.0

25.7

148

R74

ICPC

Upper respiratory infection acute

0.7

25.6

1480

14286

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

25.6

220

728

SPAT1014

SPAT

Treatment of eyes

1.9

25.6

328

1263

T05

ICPC

Feeding problem of adult

3.3

25.5

102

226

R1250, ,

SPAT

2.1

25.4

253

889

XF606, ,

SPAT

3.0

25.3

120

295

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.0

25.3

288

1065

P16

ICPC

Acute alcohol abuse

2.7

25.1

140

377

K59.0

ICD-10 Finland

Constipation

1.5

25.1

968

4958

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

4.9

25.1

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

25.1

402

1664

L75

ICPC

Fracture: femur

2.0

25.0

277

1013

H02AB06

ATC

prednisolone; systemic

0.8

25.0

5871

48352

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.2

24.9

233

799

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.8

24.9

405

1684

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.6

24.5

453

5447

WYA30, ,

SPAT

3.2

24.4

103

236

F0024, G301,

ICD-10 Finland

206.8

24.4

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.1

24.4

109

259

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

3.6

24.3

182

XF606

NOMESCO Finland

Ortostatic test

2.6

24.2

149

423

A10BK01

ATC

dapagliflozin; oral

0.6

24.2

406

5002

U13

ICPC

Bladder symptom/complaint other

1.7

24.1

452

1958

C04AE01

ATC

ergoloid mesylates; systemic

2.5

24.1

167

503

G40

ICD-10 Finland

Epilepsy

3.0

24.0

111

269

F009, G301,

ICD-10 Finland

+∞

24.0

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

24.0

593

2760

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.7

23.9

704

7636

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

23.8

1661

9393

P18

ICPC

Medication abuse

4.1

23.6

125

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.5

23.5

760

3758

A27

ICPC

Fear of other disease NOS

1.5

23.4

713

3481

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

23.3

166

2669

S01

ICD-10 Finland

Open wound of head

2.2

23.3

200

662

WF002

NOMESCO Finland

Radical radiotherapy

0.6

23.3

347

4412

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

4.5

23.1

F0004, G300,

ICD-10 Finland

+∞

23.0

F0280, G318,

ICD-10 Finland

+∞

23.0

N07AA06, ,

ATC

+∞

23.0

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.7

22.8

435

1894

K08.3

ICD-10 Finland

Retained dental root

1.4

22.8

1019

5365

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

22.7

6317

41553

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.5

22.6

713

3507

P04

ICPC

Feeling/behaving irritable/angry

4.5

22.6

I67.4

ICD-10 Finland

Hypertensive encephalopathy

7.2

22.5

L08

ICPC

Shoulder symptom/complaint

0.8

22.5

1860

17117

WW200, ,

SPAT

0.8

22.5

1813

16737

S22.3

ICD-10 Finland

Fracture of rib

1.4

22.4

991

5206

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.0

22.4

107

265

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

22.4

1108

5938

Z51.88

ICD-10 Finland

Other specified medical care

1.9

22.3

312

1238

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.0

22.3

266

1001

D82

ICPC

Teeth/gum disease

0.8

22.2

2480

22034

3319X

ICD-9 Finland

Other cerebral degenerations, Cerebral degeneration, unspecified

+∞

22.1

S82

ICPC

Naevus/mole

0.7

22.1

913

9306

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

29.4

22.0

R03AC02

ATC

salbutamol; inhalant

0.8

22.0

5825

47665

R45.5

ICD-10 Finland

Hostility

10.2

22.0

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

21.9

458

2043

GD1AA, ,

SPAT

0.5

21.9

261

3535

G91.0

ICD-10 Finland

Communicating hydrocephalus

3.1

21.9

100

241

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.7

21.8

630

6861

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

5.7

21.8

K70.1

ICD-10 Finland

Alcoholic hepatitis

3.5

21.7

175

IHZ08, ,

SPAT

4.8

21.5

F32

ICD-10 Finland

Depressive episode

1.7

21.5

391

1681

Z01.2

ICD-10 Finland

Dental examination

0.8

21.4

3588

30590

K92.0

ICD-10 Finland

Haematemesis

1.7

21.3

401

1739

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

2.7

21.2

118

318

3312X

ICD-9 Finland

Other cerebral degenerations, Senile degeneration of brain

+∞

21.2

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.5

21.1

141

418

S28

ICPC

Limited function/disability (S)

2.6

21.0

132

379

N05BA01

ATC

diazepam; systemic, rectal

1.3

20.8

1814

10569

F0023, G308,

ICD-10 Finland

176.5

20.8

N02AX02

ATC

tramadol; systemic, rectal

0.8

20.8

5244

43146

L03AA13

ATC

pegfilgrastim; parenteral

0.4

20.7

144

2333

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

20.7

839

4338

N05AH02

ATC

clozapine; systemic

2.9

20.6

104

266

A01

ICPC

Pain general/multiple sites

1.3

20.5

1263

7006

N05AB03

ATC

perphenazine; systemic, rectal

1.7

20.5

359

1526

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

20.5

3153

27125

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

4.3

20.5

100

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

6.8

20.4

S06.3

ICD-10 Finland

Focal brain injury

2.1

20.4

204

720

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.6

20.4

309

3907

I95.9

ICD-10 Finland

Hypotension, unspecified

1.9

20.3

274

1075

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

20.3

1116

6082

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

20.3

1836

10746

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.7

20.2

750

7795

J01FA10

ATC

azithromycin; systemic

0.8

20.2

4956

40905

R40.2

ICD-10 Finland

Coma, unspecified

2.3

20.2

157

499

XQ858, ,

SPAT

3.5

20.2

162

R63.4

ICD-10 Finland

Abnormal weight loss

1.5

20.1

586

2833

A10BJ06

ATC

semaglutide; parenteral

0.4

20.1

113

1989

ZXD35

NOMESCO Finland

Usual procedure

1.6

20.0

460

2103

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.2

20.0

172

571

N05AA02

ATC

levomepromazine; systemic

1.6

20.0

457

2088

Z08

ICPC

Social welfare problem

2.4

19.9

147

457

R45.1

ICD-10 Finland

Restlessness and agitation

4.4

19.9

N06AX21

ATC

duloxetine; oral

1.4

19.8

1166

6423

S42.0

ICD-10 Finland

Fracture of clavicle

1.8

19.7

332

1397

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

3.7

19.5

134

Z11

ICPC

Compliance/being ill problem

2.7

19.4

113

313

D07AA02

ATC

hydrocortisone; topical

1.3

19.3

1562

9006

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

2.2

19.3

174

589

XQ855, ,

SPAT

2.5

19.3

130

387

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.3

19.3

146

459

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.4

19.2

139

428

M70.6

ICD-10 Finland

Trochanteric bursitis

0.7

19.2

1093

10599

U28

ICPC

Limited function/disability (U)

2.0

19.1

202

728

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

18.9

1729

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.8

18.9

251

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

2.1

18.9

188

663

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

84.6

18.8

G04BD08

ATC

solifenacin; oral

1.4

18.8

1120

6184

A78

ICPC

Infectious disease other/NOS

2.2

18.7

157

516

C09CA06

ATC

candesartan; oral

0.8

18.7

2210

19558

S01.9

ICD-10 Finland

Open wound of head, part unspecified

1.9

18.7

250

979

P19

ICPC

Drug abuse

4.2

18.6

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.5

18.6

173

2529

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.9

18.6

238

919

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.3

18.6

148

476

A04AA55

ATC

palonosetron, combinations; systemic

0.3

18.5

1195

S09.9

ICD-10 Finland

Unspecified injury of head

2.0

18.5

214

797

A10BB12

ATC

glimepiride; oral

1.3

18.5

1396

7974

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

18.5

134

2135

M25.5

ICD-10 Finland

Pain in joint

0.8

18.4

2444

21372

SPAT1125

SPAT

Stoma care and guidance

1.7

18.4

333

1430

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

18.4

1921

17235

D19

ICPC

Teeth/gum symptom/complaint

0.8

18.4

1813

16373

ZY000

NOMESCO Finland

Hospital inpatient

2.8

18.4

263

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

5.5

18.3

E87.6

ICD-10 Finland

Hypokalaemia

1.6

18.3

496

2361

G04BD07

ATC

tolterodine; oral

1.4

18.3

888

4742

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

18.3

748

3875

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.8

18.2

256

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.5

18.1

142

2201

WZC30, ,

SPAT

0.6

18.1

280

3522

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.6

18.1

272

3447

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

18.1

1406

13069

R03BA08

ATC

ciclesonide; inhalant

0.6

18.0

445

5008

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.5

18.0

116

338

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

44.1

18.0

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

18.0

1746

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.8

18.0

1117

10702

ZXA00

NOMESCO Finland

Right side

1.2

18.0

4262

27528

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.8

17.9

2294

20138

Z75.0

ICD-10 Finland

Medical services not available in home

3.6

17.9

132

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

4.1

17.9

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

17.8

4557

29612

W0A10, ,

SPAT

8.3

17.8

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.4

17.8

827

4384

P99

ICPC

Psychological disorders other

2.1

17.7

172

601

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.4

17.7

129

399

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

3.0

17.7

204

M03BX02

ATC

tizanidine; oral

0.9

17.6

5739

46476

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

5.8

17.6

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

5.8

17.6

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.2

17.5

153

512

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

17.5

955

5198

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.5

17.4

500

2413

OAA80, ,

SPAT

0.2

17.3

833

L57.0

ICD-10 Finland

Actinic keratosis

0.8

17.3

1389

12859

R06.0

ICD-10 Finland

Dyspnoea

0.8

17.2

3366

28407

A10AE05

ATC

insulin detemir; parenteral

1.4

17.2

690

3563

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

17.1

1488

8657

C03DA01

ATC

spironolactone; oral

0.8

17.1

1509

13813

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.5

17.0

202

2736

PJA12

NOMESCO Finland

Sentinel node biopsy

0.7

17.0

453

5019

N03AF01

ATC

carbamazepine; oral, rectal

1.4

17.0

713

3711

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.8

17.0

2253

19721

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

1.9

17.0

226

885

G11.9

ICD-10 Finland

Hereditary ataxia, unspecified

4.4

16.9

R25.1

ICD-10 Finland

Tremor, unspecified

1.6

16.8

436

2054

B01AB10

ATC

tinzaparin; parenteral

0.7

16.7

734

7413

WX199

NOMESCO Finland

Other local analgesia

0.5

16.6

195

2648

F0019, G309,

ICD-10 Finland

+∞

16.6

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.4

16.5

644

3306

E66.01

ICD-10 Finland

Obesity due to excess calories

0.6

16.5

238

3050

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

0.8

16.5

1225

11462

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.6

16.4

354

1595

L03

ICPC

Low back symptom/complaint

0.8

16.4

2410

20894

SPAT1058

SPAT

PEF monitoring instruction

0.7

16.4

582

6097

IGP01

NOMESCO Finland

Psychiatric family contact

4.4

16.4

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.6

16.3

357

1614

SPAT1265

SPAT

Breathalyser

3.0

16.3

186

OAB48, ,

SPAT

0.4

16.3

105

1747

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.5

16.3

585

2957

J96.1

ICD-10 Finland

Chronic respiratory failure

0.5

16.3

143

2128

S00.8

ICD-10 Finland

Superficial injury of other parts of head

1.9

16.3

220

866

L03AA02

ATC

filgrastim; parenteral

0.4

16.3

102

1715

ZXD05

NOMESCO Finland

Urgent procedure

1.2

16.2

4278

27830

G20

ICD-10 Finland

Parkinson disease

1.5

16.2

604

3076

M04AA01

ATC

allopurinol; systemic

0.8

16.1

1820

16211

SPAT1111

SPAT

Planning of analgesia

2.0

16.1

173

629

H04AA01

ATC

glucagon; nasal, parenteral

2.2

16.1

139

464

SFA20

NOMESCO Finland

Two-surface restoration

0.9

16.1

4950

40335

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

8.4

16.0

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

3.4

15.9

132

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.1

15.9

152

528

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

2.7

15.9

238

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.0

15.8

177

653

G41.9

ICD-10 Finland

Status epilepticus, unspecified

2.6

15.8

268

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.3

15.8

1306

7550

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.2

15.7

139

468

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.6

15.7

325

3802

F0204, G310,

ICD-10 Finland

+∞

15.7

F0203, G310,

ICD-10 Finland

+∞

15.7

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

5.3

15.7

WX290

NOMESCO Finland

Other blockage of nerve

0.8

15.6

3006

25443

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.8

15.6

207

A69.2

ICD-10 Finland

Lyme disease

0.6

15.6

285

3436

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

15.6

874

N07

ICPC

Convulsion/seizure

4.7

15.5

TDA90, ,

SPAT

0.6

15.5

340

3924

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.7

15.4

579

6007

L90

ICPC

Osteoarthrosis of knee

0.7

15.4

521

5508

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

5.3

15.4

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

2.8

15.4

213

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.3

15.4

119

379

SPAT1042

SPAT

Guidance concerning balance maintenance

2.5

15.4

103

307

N05BE01

ATC

buspirone; oral

1.7

15.3

270

1153

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.5

15.3

533

2678

T68

ICD-10 Finland

Hypothermia

2.8

15.3

218

G31

ICD-10 Finland

Other degenerative diseases of nervous system, not elsewhere classified

24.2

15.3

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

15.2

317

3703

ZXA05

NOMESCO Finland

Left side

1.2

15.2

3968

25767

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.3

15.2

1116

K86

ICPC

Hypertension uncomplicated

0.8

15.1

1422

12928

N05BA02

ATC

chlordiazepoxide; systemic

1.7

15.1

282

1225

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.4

15.0

105

319

SPAT1285

SPAT

Provision of consultation response

1.4

15.0

706

3750

XA400

NOMESCO Finland

EEG

2.7

15.0

241

F10.59

ICD-10 Finland

Alcohol psychosis, mixed type

7.7

15.0

N80

ICPC

Head injury other

1.8

14.8

236

979

F000, G300,

ICD-10 Finland

+∞

14.7

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

14.7

F0001, G300,

ICD-10 Finland

+∞

14.7

F0200, G310,

ICD-10 Finland

+∞

14.7

S01.7

ICD-10 Finland

Multiple open wounds of head

2.5

14.7

100

300

G91.1

ICD-10 Finland

Obstructive hydrocephalus

3.2

14.7

143

S72.2

ICD-10 Finland

Subtrochanteric fracture

2.0

14.7

165

610

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.6

14.7

261

N03AE01

ATC

clonazepam; systemic

1.4

14.6

669

3537

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.4

14.6

105

324

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

14.5

435

2119

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

14.5

931

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.3

14.4

940

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

2.0

14.4

157

574

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.8

14.4

192

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.9

14.4

5065

40978

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

4.5

14.4

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

4.0

14.4

SPAT1227

SPAT

Substance abuse rehabilitation

3.8

14.4

F10.6

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Amnesic syndrome

7.7

14.4

HA1AA, ,

SPAT

0.2

14.4

819

K91

ICPC

Cerebrovascular disease

1.8

14.3

239

1005

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.2

14.3

2288

14234

WX111

NOMESCO Finland

Local infiltration anesthesia

0.6

14.3

191

2495

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

14.3

144

512

N18

ICPC

Paralysis/weakness

1.6

14.2

307

1385

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

14.2

1275

N03AF02

ATC

oxcarbazepine; oral

1.6

14.2

348

1620

WW500

NOMESCO Finland

Blood transfusion

0.6

14.2

252

3057

A05

ICPC

Feeling ill

1.5

14.1

497

2503

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

0.7

14.1

499

5232

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.3

14.1

938

5262

115

Kela drug reimbursment

Breast cancer

0.7

14.0

535

5534

ZX120, ,

SPAT

2.1

13.9

135

473

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

13.9

3898

25433

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

0.7

13.8

372

4110

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

2.7

13.8

205

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

1.9

13.8

189

749

A10BH05

ATC

linagliptin; oral

1.3

13.7

905

5070

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.9

13.7

4692

38066

S15

ICPC

Foreign body in skin

0.7

13.7

423

4549

AA1CG, ,

SPAT

2.3

13.7

103

324

R01AD59

ATC

mometasone, combinations; nasal

0.3

13.7

948

Z10.0

ICD-10 Finland

Occupational health examination

0.3

13.7

970

S20.2

ICD-10 Finland

Contusion of thorax

1.4

13.7

609

3206

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

1.8

13.6

213

879

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.2

13.6

131

JN4BD

NOMESCO Finland

Extensive body CT

0.8

13.6

1042

9720

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.7

13.6

279

1243

HA1AA

NOMESCO Finland

X-ray mammography

0.7

13.6

441

4696

NG1AA, ,

SPAT

0.5

13.6

106

1640

F0289, G318,

ICD-10 Finland

117.6

13.6

T08

ICPC

Weight loss

1.8

13.6

219

913

SPAT1104

SPAT

Monitoring of emergency patient

1.3

13.6

923

5196

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.5

13.5

149

2058

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.5

13.5

112

1695

R4110, ,

SPAT

0.7

13.5

597

6022

S01BC05

ATC

ketorolac; ophthalmic

1.4

13.5

739

4028

G04BD12

ATC

mirabegron; oral

1.2

13.5

1929

11868

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.8

13.4

2829

23807

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.7

13.4

430

4591

SGA01

NOMESCO Finland

Emergency treatment

0.7

13.4

658

6533

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.6

13.4

307

1407

G93.4

ICD-10 Finland

Encephalopathy, unspecified

3.5

13.3

100

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.1

13.3

131

462

N03AX18

ATC

lacosamide; systemic

2.7

13.3

197

SGB30

NOMESCO Finland

Other complicated root filling

0.6

13.3

286

3313

T93

ICPC

Lipid disorder

0.7

13.3

441

4676

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

0.6

13.3

249

2978

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.4

13.3

593

3124

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.8

13.2

942

8866

L13

ICPC

Hip symptom/complaint

0.8

13.2

1921

16699

SPAT1244

SPAT

Occupational therapy

2.0

13.1

152

569

R50.9

ICD-10 Finland

Fever, unspecified

1.2

13.1

1947

12018

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

2.9

13.1

162

M76.6

ICD-10 Finland

Achilles tendinitis

0.6

13.0

187

2395

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.4

13.0

500

2562

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

13.0

134

481

D06BB10

ATC

imiquimod; topical

0.7

13.0

363

3976

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.4

12.9

1095

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.2

12.9

110

366

K70.4

ICD-10 Finland

Alcoholic hepatic failure

3.1

12.9

132

K05.30

ICD-10 Finland

Periodontitis complex

0.8

12.8

1077

9933

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

0.5

12.8

118

1724

N05AN01

ATC

lithium; oral

1.9

12.8

162

626

SFA30

NOMESCO Finland

Three-surface restoration

0.9

12.8

3582

29502

K02.0

ICD-10 Finland

Caries limited to enamel

0.7

12.8

726

7049

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.4

12.7

1246

R2110

NOMESCO Finland

Giving the first information

1.4

12.7

628

3367

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

12.6

1301

7725

S32.5

ICD-10 Finland

Fracture of pubis

1.9

12.6

166

650

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

1.6

12.6

280

1275

L01

ICPC

Neck symptom/complaint

0.8

12.6

1088

9998

R44.0

ICD-10 Finland

Auditory hallucinations

2.8

12.6

170

SGC00

NOMESCO Finland

Medication, disinfection of root canals

0.7

12.5

426

4497

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.6

12.5

304

3428

SPAT1260

SPAT

Consultation of another employee

1.2

12.5

2433

15397

N19

ICPC

Speech disorder

1.8

12.5

186

758

R35

ICD-10 Finland

Polyuria

1.3

12.4

1002

5775

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

12.4

388

1911

D64.9

ICD-10 Finland

Anaemia, unspecified

1.2

12.4

1998

12431

I49.3

ICD-10 Finland

Ventricular premature depolarization

0.7

12.3

517

5261

S52.0

ICD-10 Finland

Fracture of upper end of ulna

1.8

12.3

198

826

W10

ICD-10 Finland

Fall on and from stairs and steps

1.4

12.3

634

3424

4289X

ICD-9 Finland

Heart failure, unspecified

0.2

12.3

558

A84

ICPC

Poisoning by medical agent

7.0

12.2

Z74.1

ICD-10 Finland

Need for assistance with personal care

7.0

12.2

NK6AN

NOMESCO Finland

Total body bone isotope imaging

0.6

12.2

156

2061

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

12.2

632

S12

ICPC

Insect bite/sting

0.7

12.2

681

6628

K90

ICPC

Stroke/cerebrovascular accident

1.4

12.2

502

2609

A01AB09

ATC

miconazole; local oral

1.3

12.1

1219

7217

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

0.7

12.1

383

4096

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.7

12.1

572

5707

G04BX04, ,

ATC

1.6

12.0

306

1439

KMAK, ,

NOMESCO Finland

1.1

12.0

5281

35468

P03

ICPC

Feeling depressed

1.4

12.0

534

2812

DFF00

NOMESCO Finland

Pure tone audiometry

0.8

12.0

954

8858

ZXY03

NOMESCO Finland

Occupational therapist

6.5

12.0

3318X

ICD-9 Finland

Other cerebral degenerations, Other cerebral degeneration

+∞

12.0

F0282, G318,

ICD-10 Finland

+∞

12.0

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.5

11.9

118

1684

W18

ICD-10 Finland

Other fall on same level

2.2

11.9

101

336

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.6

11.9

295

1380

M54.4

ICD-10 Finland

Lumbago with sciatica

0.8

11.9

1260

11316

K80

ICPC

Cardiac arrhythmia NOS

0.7

11.8

669

6499

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

0.8

11.8

2047

17530

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.6

11.8

229

2714

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

3.7

11.8

L02BG04

ATC

letrozole; oral

0.7

11.8

362

3892

G04CB02

ATC

dutasteride; oral

1.2

11.8

1405

8479

A23

ICPC

Risk factor NOS

1.4

11.7

658

3601

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.7

11.7

177

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

4.7

11.7

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

1.6

11.7

257

1168

WX404

NOMESCO Finland

Intravenous generell anesthesy

0.8

11.7

1654

14427

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

2.8

11.6

165

XCH00

NOMESCO Finland

Eye pressure measurement

0.7

11.6

378

4021

T82

ICPC

Obesity

0.4

11.6

1085

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

1.8

11.6

187

781

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.7

11.6

346

3740

A11CC03

ATC

alfacalcidol; systemic

0.5

11.6

119

1676

L03AA14

ATC

lipegfilgrastim; parenteral

0.3

11.6

776

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

11.6

1171

6939

AA1AA

NOMESCO Finland

Head X-ray examination

2.0

11.5

120

433

ZX120

NOMESCO Finland

Intravenous

0.8

11.5

800

7556

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.7

11.5

207

893

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

3.7

11.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.3

11.4

735

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

0.6

11.4

214

2554

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

0.5

11.4

137

1839

UJF30

NOMESCO Finland

Ileoscopy through colon

0.8

11.3

738

7031

N05AL01

ATC

sulpiride; systemic

1.8

11.3

173

711

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.8

11.3

1242

11111

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.3

11.2

283

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.6

11.2

226

2656

WF004

NOMESCO Finland

Palliative radiotherapy

0.5

11.2

111

1583

B01AC07

ATC

dipyridamole; systemic

1.3

11.2

1058

6216

N02BF01

ATC

gabapentin; oral

0.7

11.2

518

5185

250, ,

Kela drug reimbursment

0.4

11.2

939

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.8

11.1

974

8940

N06AX03

ATC

mianserin; oral

1.4

11.1

576

3114

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.6

11.1

243

1104

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

11.1

792

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

11.1

617

F0009, G309,

ICD-10 Finland

+∞

11.1

ACC51

NOMESCO Finland

Release of median nerve

0.7

11.0

421

4352

F02.82

ICD-10 Finland

Dementia in other specified disease that is classified elsewhere other symptoms, mainly hallucinations

20.8

11.0

T74.1

ICD-10 Finland

Physical abuse

2.5

11.0

218

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.4

11.0

1141

SPAT1255

SPAT

Intravenous administration of medicine

1.3

10.9

922

5343

N88

ICPC

Epilepsy

2.5

10.9

201

D10

ICPC

Vomiting

1.5

10.9

308

1486

Z43.5

ICD-10 Finland

Attention to cystostomy

2.0

10.9

118

433

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.5

10.8

123

1680

H43.8

ICD-10 Finland

Other disorders of vitreous body

0.8

10.8

683

6536

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

1.8

10.8

162

662

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

0.7

10.8

339

3630

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

2.2

10.8

307

HMAK, ,

NOMESCO Finland

0.8

10.8

654

6292

G03DC02

ATC

norethisterone; oral

0.7

10.8

520

5172

DAX08

NOMESCO Finland

Fitting of hearing aid

0.7

10.8

569

5582

L89

ICPC

Osteoarthrosis of hip

0.6

10.8

246

2807

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

1.9

10.7

130

496

P01

ICPC

Feeling anxious/nervous/tense

1.4

10.7

510

2719

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

2.6

10.7

173

Y94.8

ICD-10 Finland

Other leisure activity accident

1.5

10.7

293

1404

NF3AA

NOMESCO Finland

Femur X-ray examination

1.5

10.6

320

1565

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.3

10.6

668

3721

SPAT1377

SPAT

Polysomnography

0.5

10.6

100

1446

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

2.6

10.6

178

SPAT1138

SPAT

Guidance concerning bowel function

1.6

10.6

226

1020

G11.2

ICD-10 Finland

Late-onset cerebellar ataxia

4.8

10.6

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

0.9

10.6

3945

31943

N05AF03

ATC

chlorprothixene; systemic

1.7

10.6

194

842

G41.0

ICD-10 Finland

Grand mal status epilepticus

3.6

10.5

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

0.7

10.5

331

3541

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

1.8

10.5

167

695

WX723

NOMESCO Finland

CPAP therapy

0.5

10.5

108

1520

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.8

10.5

1012

9190

N03AX09

ATC

lamotrigine; oral

1.6

10.5

245

1132

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

0.7

10.5

325

3484

128

Kela drug reimbursment

Cancers of female genital organs

0.4

10.4

942

I50.1

ICD-10 Finland

Left ventricular failure

0.8

10.4

613

5922

J01FA09

ATC

clarithromycin; systemic

0.9

10.4

2554

21283

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

0.7

10.4

343

3634

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

0.6

10.4

189

2270

F30.1

ICD-10 Finland

Mania without psychotic symptoms

5.0

10.3

N05AC01

ATC

periciazine; systemic

2.6

10.3

176

SPAT1243

SPAT

Psychiatric/psychological examination

2.0

10.3

113

416

A12AA04

ATC

calcium carbonate; oral

0.4

10.3

1032

R5140

NOMESCO Finland

Monitoring the use of the aid

0.8

10.3

810

7531

N04AA02

ATC

biperiden; systemic

1.7

10.3

175

744

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

0.7

10.3

341

3610

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

3.6

10.3

OAB42, ,

SPAT

0.7

10.2

587

5691

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.1

10.2

6547

44845

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

10.2

1390

8501

F0021, G301,

ICD-10 Finland

34.3

10.2

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.3

10.2

608

3360

R03AK08

ATC

formoterol and beclometasone; inhalant

0.6

10.2

200

2362

NA3BG, ,

SPAT

0.5

10.2

1119

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.8

10.2

723

6810

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.1

10.2

3304

21714

L04AX03

ATC

methotrexate; systemic

0.8

10.2

597

5769

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.0

10.1

109

399

G32.0*E53.8

ICD-10 Finland

Subacute combined degeneration of the spinal cord in case of vitamin B12 deficiency

+∞

10.1

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

1.8

10.1

164

687

H02.3

ICD-10 Finland

Blepharochalasis

0.7

10.1

529

5196

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.6

10.1

161

1999

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.5

10.1

114

1557

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.2

10.0

482

R31

ICD-10 Finland

Unspecified haematuria

1.2

10.0

1785

11196

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.4

10.0

1071

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.4

10.0

796

F009, G308,

ICD-10 Finland

88.2

10.0

S42.4

ICD-10 Finland

Fracture of lower end of humerus

1.8

10.0

139

556

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.1

10.0

6094

41618

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

10.0

448

4504

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

0.5

10.0

1129

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

0.2

9.9

540

R05

ICD-10 Finland

Cough

0.9

9.9

1989

16844

N84.0

ICD-10 Finland

Polyp of corpus uteri

0.7

9.9

365

3792

IGV01

NOMESCO Finland

Psychiatric network contact

3.1

9.9

102

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.5

9.9

284

1376

183

Kela drug reimbursment

Lamotrigin and topiramate

2.4

9.9

216

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.8

9.8

1970

16687

OAB95, ,

SPAT

0.3

9.8

655

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.8

9.8

975

8824

GD1AD

NOMESCO Finland

Thorax CT examination

0.7

9.8

435

4383

ZXC96

NOMESCO Finland

Robot assisted procedure

0.5

9.8

1320

L01CA04

ATC

vinorelbine; systemic

0.2

9.8

523

SPAT1109

SPAT

Analgesia with portable analgesic pump

2.0

9.8

100

360

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

9.8

9.7

L76

ICPC

Fracture: other

1.4

9.7

418

2194

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

5.7

9.7

OAA65, ,

SPAT

0.5

9.7

101

1411

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

1.7

9.6

165

703

R05

ICPC

Cough

0.9

9.6

2178

18275

F02.00

ICD-10 Finland

Dementia in Pick's disease without additional symptoms

25.7

9.6

F02.8

ICD-10 Finland

Dementia in other specified diseases classified elsewhere

25.7

9.6

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

5.3

9.6

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

5.3

9.6

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

1.9

9.6

119

459

C10AA02

ATC

lovastatin; oral

1.3

9.6

772

4451

N43

ICPC

Neurological, Other diagnostic procedure

2.3

9.6

247

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.3

9.5

551

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.9

9.5

2633

21774

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

5.1

9.5

G04BD10

ATC

darifenacin; oral

2.0

9.5

110

414

A04AD12

ATC

aprepitant; systemic

0.4

9.5

765

R21

ICPC

Throat symptom/complaint

0.8

9.5

1013

9096

TFP34

NOMESCO Finland

Electrophysiological investigation

0.5

9.5

1384

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.4

9.5

861

N03AB02

ATC

phenytoin; systemic

1.7

9.5

166

712

A86

ICD-10 Finland

Unspecified viral encephalitis

2.4

9.4

198

X31

ICD-10 Finland

Exposure to excessive natural cold

2.9

9.4

121

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

0.5

9.4

1330

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

1.7

9.3

158

671

L01CB01

ATC

etoposide; systemic

0.2

9.3

290

Z10.1

ICD-10 Finland

Routine general health check-up of inhabitants of institutions

5.4

9.3

XCW10, ,

SPAT

0.2

9.3

291

T11

ICPC

Dehydration

3.5

9.3

WX722

NOMESCO Finland

PEEP

0.7

9.3

313

3302

D21

ICPC

Swallowing problem

1.6

9.3

213

981

A10AD05

ATC

insulin aspart; parenteral

1.5

9.3

331

1678

F91.9

ICD-10 Finland

Conduct disorder, unspecified

12.5

9.3

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

9.3

387

2020

B01AA03

ATC

warfarin; systemic

1.1

9.2

4199

28172

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.4

9.2

389

2034

G03AC03

ATC

levonorgestrel; oral, implant

0.6

9.2

226

2537

IHA10, ,

SPAT

2.0

9.2

358

F0202, G310,

ICD-10 Finland

+∞

9.2

SFA10

NOMESCO Finland

One-surface restoration

0.9

9.2

5045

40008

M02AA07

ATC

piroxicam; topical

1.1

9.2

5395

36720

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.8

9.2

778

7170

F22.8

ICD-10 Finland

Other persistent delusional disorders

3.7

9.2

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.1

9.2

334

R47.0

ICD-10 Finland

Dysphasia and aphasia

1.7

9.1

161

692

S21

ICPC

Skin texture symptom/complaint

0.8

9.1

1379

11965

B01AF01

ATC

rivaroxaban; oral

0.8

9.1

1474

12712

-, ,

ICD-10 Finland

1.5

9.1

296

1474

ZXD20

NOMESCO Finland

Day surgery

1.2

9.1

1470

9142

HAB40

NOMESCO Finland

Wedge excision of mammary gland

0.7

9.1

281

3011

S32.4

ICD-10 Finland

Fracture of acetabulum

1.9

9.1

115

447

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.4

9.0

341

1747

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.1

9.0

7162

49519

S01.2

ICD-10 Finland

Open wound of nose

1.7

9.0

176

779

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

1.9

9.0

111

428

ZX080

NOMESCO Finland

Image guided radiotherapy

0.5

9.0

1154

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

3.9

8.9

NH3AA, ,

SPAT

0.4

8.9

796

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.3

8.9

642

3648

SGA02

NOMESCO Finland

Opening and preparing the root canals

0.8

8.9

751

6923

S01EX03, ,

ATC

1.4

8.9

415

2209

G40.7

ICD-10 Finland

Petit mal, unspecified, without grand mal seizures

4.0

8.9

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

2.7

8.8

134

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.8

8.8

1719

14601

6271A

ICD-9 Finland

Menopausal and postmenopausal disorders, Postmenopausal bleeding

1.6

8.8

197

902

A96

ICPC

Death

1.9

8.8

103

390

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

2.8

8.8

114

Z74.0

ICD-10 Finland

Need for assistance due to reduced mobility

4.2

8.8

N81.6

ICD-10 Finland

Rectocele

0.7

8.7

432

4276

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.5

8.7

1183

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.5

8.7

983

S06.2

ICD-10 Finland

Diffuse brain injury

1.9

8.7

112

438

E66

ICD-10 Finland

Obesity

0.5

8.7

107

1422

D17

ICPC

Incontinence of bowel

1.8

8.7

139

582

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.7

8.7

379

3824

L01AX03

ATC

temozolomide; systemic

0.1

8.7

224

6000A

ICD-9 Finland

Hyperplasia of prostate[HYPERPLASIA PROSTATAE]

1.4

8.6

353

1836

P27

ICPC

Fear of mental disorder

2.2

8.6

244

Z27

ICPC

Fear of a social problem

2.8

8.6

115

ZY010

NOMESCO Finland

Hospital outpatient

1.4

8.6

324

1661

G04BD04

ATC

oxybutynin; oral, transdermal

1.3

8.6

877

5205

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

0.7

8.6

249

2700

SPAT1240

SPAT

Therapeutic discussion

1.3

8.6

657

3766

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.5

8.6

1027

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.8

8.5

916

8219

TKC20

NOMESCO Finland

Catheterisation of bladder

1.2

8.5

1145

6996

ZYY01

NOMESCO Finland

Contact between professionals

4.1

8.5

S01.3

ICD-10 Finland

Open wound of ear

1.7

8.5

147

629

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.5

8.5

1152

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

0.2

8.5

318

C08CA13

ATC

lercanidipine; oral

0.9

8.4

1773

14970

N05CD08

ATC

midazolam; nasal, systemic

1.4

8.4

322

1655

EBA00

NOMESCO Finland

Extraction of tooth

1.1

8.4

3926

26356

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.2

8.4

242

S97

ICPC

Chronic ulcer skin

1.2

8.4

933

5588

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

0.4

8.4

878

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

1.8

8.4

123

502

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

0.6

8.4

141

1722

RT250, ,

NOMESCO Finland

3.7

8.3

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

0.8

8.3

726

6665

K92.1

ICD-10 Finland

Melaena

1.2

8.3

873

5197

SPAT1236

SPAT

Informing family of child’s disability

1.5

8.3

243

1184

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

0.5

8.3

102

1356

U29

ICPC

Urinary symptom/complaint other

1.4

8.3

392

2091

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.4

8.3

675

F062, G310,

ICD-10 Finland

+∞

8.3

F0201, G310,

ICD-10 Finland

+∞

8.3

F0010, G308,

ICD-10 Finland

+∞

8.3

C45.0

ICD-10 Finland

Mesothelioma of pleura

0.1

8.3

220

HA1AE, ,

SPAT

0.2

8.3

446

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

0.3

8.3

540

R44

ICPC

Respiratory, Preventive immunization/medic

1.5

8.3

241

1174

UKC02

NOMESCO Finland

Cystoscopy

1.1

8.3

2861

18860

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

0.6

8.3

127

1587

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.4

8.3

322

1662

NF1AA, ,

SPAT

0.5

8.2

1062

A07

ICPC

Coma

2.3

8.2

202

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.3

8.2

475

2617

Q90.9

ICD-10 Finland

Down syndrome, unspecified

73.5

8.2

F0014, G309,

ICD-10 Finland

73.5

8.2

Y07

ICD-10 Finland

Other maltreatment

3.0

8.2

TK800

NOMESCO Finland

Hemodialysis

0.5

8.2

1245

H01

ICPC

Ear pain/earache

0.8

8.2

647

6007

R81

ICPC

Pneumonia

1.4

8.2

439

2393

K85

ICPC

Elevated blood pressure

0.9

8.2

1957

16361

RT150, ,

NOMESCO Finland

4.4

8.1

N06AB03

ATC

fluoxetine; oral

1.2

8.1

1190

7332

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

7.0

8.1

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.1

8.1

4887

33265

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

1.4

8.1

301

1540

B01AC24

ATC

ticagrelor; oral

0.7

8.1

232

2520

P72

ICPC

Schizophrenia

1.9

8.1

104

407

G40.89

ICD-10 Finland

Other epilepsy

2.5

8.1

145

XF600, ,

SPAT

1.4

8.1

339

1773

P71

ICPC

Organic psychosis other

8.3

8.1

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.2

8.1

1572

9935

TGC00

NOMESCO Finland

Bronchial lavation

0.6

8.1

143

1724

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.3

8.1

705

4110

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.4

8.0

427

2323

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.4

8.0

749

G03CA04

ATC

estriol; systemic, vaginal

1.2

8.0

1231

7619

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

0.3

8.0

459

G03FB05

ATC

norethisterone and estrogen; systemic

0.8

8.0

765

6947

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

2.3

8.0

182

K04.5

ICD-10 Finland

Chronic apical periodontitis

0.9

8.0

2273

18774

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.2

8.0

930

5603

C09DA01

ATC

losartan and diuretics; oral

0.8

7.9

1096

9593

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.8

7.9

523

4970

R41.2

ICD-10 Finland

Retrograde amnesia

3.5

7.9

180

Kela drug reimbursment

Interferon alfa

0.1

7.9

228

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

0.7

7.9

203

2254

B81

ICPC

Anaemia vit B12/folate deficiency

1.3

7.9

593

3391

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

0.3

7.9

514

ND2AA, ,

SPAT

0.4

7.9

690

AA1FD

NOMESCO Finland

Trauma CT of head and face

3.4

7.9

G46.8

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

5.1

7.9

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

7.8

421

2295

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

0.9

7.8

2297

18940

ZYY02

NOMESCO Finland

Contact between professionals and family members

7.8

NG1BG, ,

SPAT

0.3

7.8

500

SPAT1081

SPAT

Cardiorespiratory global assessment

1.2

7.8

848

5069

K31

ICPC

Cardiovascular, Medical examin/health eval partial

1.9

7.8

386

N81.1

ICD-10 Finland

Cystocele

0.8

7.8

494

4717

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

0.8

7.8

562

5277

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.1

7.8

4066

27454

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

7.8

2002

12928

S82.0

ICD-10 Finland

Fracture of patella

1.6

7.8

202

960

C01DA14

ATC

isosorbide mononitrate; oral

1.1

7.8

3667

24619

K30

ICD-10 Finland

Functional dyspepsia

0.8

7.8

804

7242

R26

ICD-10 Finland

Abnormalities of gait and mobility

2.5

7.7

144

U70

ICPC

Pyelonephritis/pyelitis

1.6

7.7

166

754

Z93.5

ICD-10 Finland

Cystostomy status

2.5

7.7

153

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

2.4

7.7

162

K03.11

ICD-10 Finland

Abrasion dentifrice of teeth

0.5

7.7

1153

M05BA07

ATC

risedronic acid; oral

1.3

7.7

500

2806

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.5

7.7

215

1040

P76

ICPC

Depressive disorder

1.4

7.7

334

1760

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

0.6

7.6

129

1573

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.3

7.6

561

3199

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.3

7.6

195

A02BC04

ATC

rabeprazole; oral

0.8

7.6

527

4975

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

0.2

7.6

410

X59.0

ICD-10 Finland

Exposure to unspecified factor causing fracture

4.3

7.6

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

1.8

7.6

116

480

CS494

NOMESCO Finland

Other visual field testing

0.6

7.6

145

1716

V613A

ICD-9 Finland

Other family circumstances, Problems with aged parents or in-laws

9.0

7.6

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.8

7.6

1252

10783

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

0.2

7.6

297

NH3EA

NOMESCO Finland

Feet X-ray examination with load

0.5

7.6

812

R12

ICD-10 Finland

Heartburn

0.8

7.6

498

4730

U08

ICPC

Urinary retention

1.4

7.6

307

1598

WX780

NOMESCO Finland

Remote monitoring CPAP

0.6

7.5

139

1659

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

2.0

7.5

274

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

2.7

7.5

112

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

0.7

7.5

382

3758

K03.00

ICD-10 Finland

Approximal wear

0.7

7.5

287

2953

WZA30

NOMESCO Finland

Assessment of driving capacity and statement

11.4

7.5

F02.84

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere as other mixed symptoms of mixed type

13.6

7.4

N05AF05

ATC

zuclopenthixol; systemic

2.1

7.4

250

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

0.6

7.4

129

1562

JN4CD

NOMESCO Finland

Very extensive body CT

0.7

7.4

283

2916

K22

ICPC

Risk factor cardiovascular disease

0.8

7.4

523

4923

SPAT1043

SPAT

Audiometry

0.8

7.4

1280

10980

NB1BG, ,

SPAT

0.2

7.4

390

F064, G310,

ICD-10 Finland

+∞

7.4

SPAT1281

SPAT

Other administrative function

1.2

7.4

917

5562

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.4

7.4

268

1367

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.0

7.4

271

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

0.7

7.4

312

3159

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.7

7.4

178

1998

F0001, G301,

ICD-10 Finland

66.2

7.3

SXC05

NOMESCO Finland

Other oral or dental procedure

0.7

7.3

251

2635

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.6

7.3

178

834

S02.51

ICD-10 Finland

Fracture of tooth, open

0.8

7.3

536

5021

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

7.3

414

2277

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

2.2

7.3

218

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.2

7.3

900

5454

M03BX01

ATC

baclofen; systemic

1.6

7.3

158

720

L16

ICPC

Ankle symptom/complaint

0.8

7.3

811

7248

F06.4

ICD-10 Finland

Organic anxiety disorder

4.5

7.3

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

2.8

7.3

101

F16

ICPC

Eyelid symptom/complaint

0.7

7.3

295

3009

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.2

7.3

204

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

3.1

7.3

OAB44, ,

SPAT

0.7

7.3

367

3616

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

3.0

7.3

SPA02

NOMESCO Finland

Preparation for dental prosthetics

0.6

7.3

143

1679

M76.0

ICD-10 Finland

Gluteal tendinitis

0.5

7.3

919

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.2

7.2

1216

7588

Z51.0

ICD-10 Finland

Radiotherapy session

0.5

7.2

829

L02BA01

ATC

tamoxifen; oral

0.7

7.2

197

2159

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

0.7

7.2

390

3807

T89

ICPC

Diabetes insulin dependent

1.4

7.2

276

1421

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.3

7.2

172

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

0.6

7.2

142

1667

L02BG06

ATC

exemestane; oral

0.5

7.2

807

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.5

7.2

827

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

0.2

7.2

258

A46

ICD-10 Finland

Erysipelas

1.1

7.2

2212

14464

R00.2

ICD-10 Finland

Palpitations

0.8

7.2

426

4101

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.0

7.2

274

XJH00

NOMESCO Finland

Transanal ultrasonography

1.2

7.2

1095

6777

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.4

7.2

384

2095

SPF30

NOMESCO Finland

Relining of denture

1.4

7.1

274

1412

NG2AA

NOMESCO Finland

Patella X-ray examination

0.6

7.1

158

1807

F10.7

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Residual and late-onset psychotic disorder

4.1

7.1

Z74.2

ICD-10 Finland

Need for assistance at home and no other household member able to render care

4.1

7.1

F38

ICPC

Eye, Other laboratory test NEC

0.5

7.1

874

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

1.7

7.1

122

523

I95

ICD-10 Finland

Hypotension

2.0

7.1

285

F01

ICD-10 Finland

Vascular dementia

2.0

7.1

285

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

2.3

7.1

178

F34.1

ICD-10 Finland

Dysthymia

1.5

7.1

225

1118

N30

ICD-10 Finland

Cystitis

1.2

7.1

801

4813

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.1

7.0

2255

14783

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

0.9

7.0

1485

12537

JN6AD

NOMESCO Finland

CT of torso and neck

0.5

7.0

849

TFP20

NOMESCO Finland

Cardiodefibrillation

0.8

7.0

822

7307

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

3.4

7.0

F32.0

ICD-10 Finland

Mild depressive episode

1.6

7.0

169

791

L89.9

ICD-10 Finland

Decubitus ulcer and pressure area, unspecified

4.8

7.0

Z60.2

ICD-10 Finland

Living alone

3.9

7.0

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

2.9

7.0

S29

ICPC

Skin symptom/complaint other

0.9

7.0

1987

16423

A99

ICPC

Disease/condition unspecnature/site

1.2

7.0

1172

7316

Y86

ICD-10 Finland

Sequelae of other accidents

2.2

6.9

194

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.3

6.9

599

3491

HAMTE, ,

NOMESCO Finland

2.0

6.9

288

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

2.4

6.9

139

G04CA01

ATC

alfuzosin; oral

1.1

6.9

1988

12939

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

0.8

6.9

624

5699

Z3229

NOMESCO Finland

Other healthcare associate professional

1.2

6.9

1192

7460

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.2

6.9

1194

7474

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

0.8

6.9

489

4595

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

2.4

6.8

144

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.3

6.8

557

3222

SPAT1098

SPAT

Exercise ECG

0.6

6.8

109

1345

XX2RW, ,

NOMESCO Finland

0.3

6.8

475

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

0.7

6.8

331

3278

S51.0

ICD-10 Finland

Open wound of elbow

1.6

6.8

156

722

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

0.6

6.8

132

1553

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

0.3

6.8

393

E000003, ,

ATC

1.3

6.8

416

2316

H91.1

ICD-10 Finland

Presbycusis

1.2

6.8

1327

8390

SAD01, ,

SPAT

3.8

6.8

C09DA03

ATC

valsartan and diuretics; oral

0.8

6.8

393

3795

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.2

6.8

177

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

1.6

6.8

168

792

WVA30, ,

SPAT

0.7

6.8

345

3393

N06AX12

ATC

bupropion; oral

1.4

6.7

252

1294

Z59.8

ICD-10 Finland

Other problems related to housing and economic circumstances

3.4

6.7

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

1.5

6.7

226

1137

F07.0

ICD-10 Finland

Organic personality disorder

6.6

6.7

R4135

NOMESCO Finland

Rehabilitation for hearing problems

0.7

6.7

161

1807

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

0.8

6.7

563

5185

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

0.6

6.7

128

1511

D25.0

ICD-10 Finland

Submucous leiomyoma of uterus

0.5

6.7

1038

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

0.8

6.7

852

7511

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.9

6.7

2199

18010

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

0.3

6.7

401

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

0.4

6.7

589

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.5

6.7

172

818

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

0.7

6.7

196

2114

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

0.5

6.7

803

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.5

6.7

793

F0022, G301,

ICD-10 Finland

33.1

6.7

Z3226

NOMESCO Finland

Physiotherapist

1.1

6.6

2345

15465

R96

ICPC

Asthma

0.8

6.6

765

6809

C09AA05

ATC

ramipril; oral

1.1

6.6

4449

30392

F80.1

ICD-10 Finland

Expressive language disorder

1.8

6.6

355

SPAT1127

SPAT

Enema

1.6

6.6

139

630

TNC33

NOMESCO Finland

Custom moulded brace, elbow or forearm

2.8

6.6

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.7

6.6

162

1810

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

1.8

6.6

366

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.4

6.6

254

1312

I67.2

ICD-10 Finland

Cerebral atherosclerosis

1.9

6.6

319

TPH04, ,

SPAT

1.9

6.6

314

F01.21

ICD-10 Finland

Subcortical vascular dementia without additional symptoms, mainly paranoidism

4.1

6.6

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

0.8

6.6

856

7528

WX210

NOMESCO Finland

Plexus blockade of nervus ichiadicus

2.2

6.6

175

V03AA01, ,

ATC

1.6

6.5

137

621

B04AB02, ,

ATC

1.3

6.5

362

1988

B99

ICD-10 Finland

Other and unspecified infectious diseases

1.4

6.5

259

1346

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

0.7

6.5

173

1901

H02BX01

ATC

methylprednisolone, combinations; systemic

1.2

6.5

774

4677

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

0.7

6.5

173

1900

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.9

6.5

295

N05AC02

ATC

thioridazine; oral

1.6

6.5

161

760

F0002, G300,

ICD-10 Finland

58.8

6.5

G32

ICD-10 Finland

Other degenerative disorders of nervous system in diseases classified elsewhere

58.8

6.5

F01.14

ICD-10 Finland

Multi-infarct dementia's other mixed symptoms of mixed type

4.5

6.5

R10.1

ICD-10 Finland

Pain localized to upper abdomen

0.9

6.5

1500

12577

A10BX01

ATC

guar gum; oral

1.3

6.5

631

3732

OAB27, ,

SPAT

0.0

6.5

122

F0024, G309,

ICD-10 Finland

+∞

6.5

F0003, G300,

ICD-10 Finland

+∞

6.5

F028, G318,

ICD-10 Finland

+∞

6.5

F0633, G310,

ICD-10 Finland

+∞

6.5

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

0.8

6.4

432

4090

N87

ICPC

Parkinsonism

1.4

6.4

229

1165

U05

ICPC

Urination problems other

1.2

6.4

735

4421

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

2.6

6.4

104

QAB00

NOMESCO Finland

Suture of skin of head or neck

1.6

6.4

144

663

L04AX01

ATC

azathioprine; systemic

0.7

6.4

193

2072

A10BJ02

ATC

liraglutide; parenteral

0.6

6.4

1082

F10.70

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol flashbacks

18.4

6.4

D07BC01

ATC

betamethasone and antiseptics; topical

1.2

6.4

1440

9207

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

1.9

6.4

338

F99

ICD-10 Finland

Mental disorder, not otherwise specified

1.8

6.4

402

A02

ICPC

Chills

1.9

6.4

312

M01AB05

ATC

diclofenac; systemic, rectal

0.9

6.4

7636

58681

EC1VA, ,

NOMESCO Finland

0.6

6.4

109

1320

M05BA02

ATC

clodronic acid; systemic

0.3

6.4

389

C09DA07

ATC

telmisartan and diuretics; oral

0.7

6.4

267

2703

A10BB01

ATC

glibenclamide; oral

1.2

6.4

881

5405

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

0.3

6.4

457

SPA41

NOMESCO Finland

Precision impression for fixed dental prosthesis

0.3

6.3

468

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

0.7

6.3

160

1777

KE1DG

NOMESCO Finland

Very extensive MRI of prostate

0.3

6.3

365

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.4

6.3

269

1414

A34

ICPC

General and Unspecified, Blood test

1.5

6.3

167

799

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.3

6.3

387

2156

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

0.7

6.3

286

2861

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

0.6

6.3

1188

S06.9

ICD-10 Finland

Intracranial injury, unspecified

1.9

6.3

303

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

3.0

6.3

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

0.4

6.3

605

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

2.9

6.3

G04BD09

ATC

trospium; oral

1.3

6.3

358

1973

Z46.6

ICD-10 Finland

Fitting and adjustment of urinary device

2.5

6.3

114

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

1.5

6.3

193

955

FN1AD

NOMESCO Finland

CT of coronary arteries

0.4

6.2

613

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.9

6.2

1704

14126

359

Kela drug reimbursment

Mirabegroni

1.8

6.2

357

E87.2

ICD-10 Finland

Acidosis

2.0

6.2

253

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

0.1

6.2

159

AA1ED

NOMESCO Finland

Trauma CT of head and neck

2.0

6.2

243

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

2.0

6.2

233

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.8

6.2

757

6701

RD211, ,

NOMESCO Finland

0.7

6.2

255

2591

C09DA06

ATC

candesartan and diuretics; oral

0.8

6.2

645

5800

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

1.9

6.2

274

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.4

6.2

590

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.1

6.2

1683

10910

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

0.5

6.2

821

B03XA02

ATC

darbepoetin alfa; parenteral

0.6

6.2

129

1491

N05AB01

ATC

dixyrazine; systemic

1.7

6.2

121

539

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

0.1

6.2

174

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.3

6.2

410

2311

S16

ICPC

Bruise/contusion

1.3

6.2

413

2331

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

0.7

6.1

247

2518

A57

ICPC

General and Unspecified, Physical medicine/rehabilitation

3.4

6.1

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

0.5

6.1

660

M53.1

ICD-10 Finland

Cervicobrachial syndrome

0.8

6.1

593

5375

SXA20

NOMESCO Finland

Local application of medicine to mouth

0.7

6.1

207

2174

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

2.3

6.1

138

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

2.3

6.1

138

L02BB04

ATC

enzalutamide; oral

0.5

6.1

710

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

1.8

6.1

402

R40.0

ICD-10 Finland

Somnolence

2.4

6.1

129

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.3

6.1

261

R5120

NOMESCO Finland

Preparation of an aid

1.3

6.1

410

2314

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

0.8

6.1

758

6696

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

0.5

6.1

768

T83.0

ICD-10 Finland

Mechanical complication of urinary (indwelling) catheter

2.2

6.1

157

TKE00

NOMESCO Finland

Needle biopsy of prostate

1.2

6.1

712

4295

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.3

6.1

447

SAE01, ,

NOMESCO Finland

0.3

6.1

379

D01AC02

ATC

miconazole; topical

1.2

6.1

1034

6464

Z02.8

ICD-10 Finland

Other examinations for administrative purposes

1.9

6.1

276

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

0.5

6.1

727

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

0.5

6.1

707

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

0.8

6.1

497

4588

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.9

6.1

1518

12659

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

0.8

6.0

877

7637

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

0.8

6.0

482

4464

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

0.5

6.0

853

PJA10

NOMESCO Finland

Exploration of lymph nodes

0.5

6.0

675

EP1AE

NOMESCO Finland

Neck ultrasound examination

0.8

6.0

389

3698

SPAT1312

SPAT

General health counselling

0.9

6.0

3340

26579

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

0.8

6.0

375

3582

F01.32

ICD-10 Finland

Mixed cortical and subcortical vascular dementia other additional symptoms, mainly hallucinations

7.4

6.0

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

0.3

6.0

365

B02.9

ICD-10 Finland

Zoster without complication

0.8

6.0

602

5434

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

3.7

6.0

K64.1

ICD-10 Finland

Second degree haemorrhoids

0.5

6.0

793

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

963

432

17.27

307.65

1.0

379.96

286.71

ng/l

8.50

733

261

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

974

428

17.65

307.65

1.0

618.16

757.45

ng/l

7.56

722

248

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

975

429

17.63

307.65

1.0

51.19

37.24

ng/l

9.65

733

253

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1033

1712

4.65

307.65

1.2

1.3

479.03

585.07

mg/l

4.86

946

1634

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

929

1453

4.90

307.65

1.2

1.4

9.30

20.47

e6/l

1.14

694

1147

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

928

1454

4.90

307.65

1.3

1.5

351.56

1094.46

e6/l

3.41

721

1211

(3019309) Folate [Moles/volume] in Red Blood Cells

6553

25543

2.42

307.65

1.9

1.8

1196.49

1154.57

nmol/l

2.79

4783

18819

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

937

1483

4.85

307.65

1.2

3.85

3.87

mmol/l

0.16

879

1386

(3021960) Folate [Moles/volume] in Serum or Plasma

6158

28767

1.89

303.76

1.7

1.6

20.31

20.28

nmol/l

0.04

5428

24038

(3044290) Cell count panel - Cerebral spinal fluid

821

1360

4.60

301.25

1.2

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8972

48152

1.76

270.59

2.5

2.1

90.54

93.18

pmol/l

5.68

4729

24729

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4785

22139

1.81

229.55

2.9

3.1

2.46

2.47

mmol/l

9.16

4154

19012

(3009466) Valproate [Moles/volume] in Serum or Plasma

593

961

4.66

222.61

3.8

4.0

322.22

338.63

umol/l

1.59

480

797

(3015377) Calcium [Moles/volume] in Serum or Plasma

7067

37222

1.67

208.73

2.6

3.3

2.35

mmol/l

0.15

5998

31521

(3023410) Appearance of Cerebral spinal fluid

449

603

5.59

206.50

1.3

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

8473

48660

1.55

158.80

3.9

4.6

34.33

34.20

g/l

1.20

7605

44549

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3069

14024

1.74

143.58

1.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3073

14081

1.73

142.22

1.9

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4827

24902

1.59

140.65

1.8

4727708.56

25167181.87

pmol/l

4.82

3850

19641

(3031040) Bacteria [#/volume] in Urine by Automated count

11201

69297

1.53

140.50

6.2

5.3

2976.94

1350.15

e6/l

2.18

358

1104

(3026008) Bacteria identified in Urine by Culture

6818

38266

1.51

134.16

3.9

3.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4096

20532

1.61

133.30

1.9

—

(3023368) Bacteria identified in Blood by Culture

6181

34235

1.51

127.77

4.1

4.4

—

(40768804) Tissue Pathology biopsy report

3883

39395

0.64

116.71

2.2

2.3

—

(3016018) Differential panel - Cerebral spinal fluid

376

715

3.93

115.34

1.2

1.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8633

51755

1.45

115.33

4.9

6.0

1.21

mmol/l

6.33

7697

46403

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6990

40393

1.45

112.44

2.1

2.2

77.43

80.63

nmol/l

14.49

5933

34648

(3018418) pH of Serum or Plasma

6005

33798

1.47

110.13

3.1

4.1

7.40

0.89

923

6516

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9315

57236

1.42

104.05

5.5

6.7

1.22

1.21

mmol/l

17.48

7792

47889

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10101

84322

0.71

93.97

3.6

4.3

1.21

1.25

mmol/l

7.48

8548

73822

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10519

87116

0.71

91.89

4.0

4.8

1.45

1.44

mmol/l

0.54

9064

77151

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10718

88061

0.72

83.70

4.1

4.9

4.32

4.38

mmol/l

6.48

9289

78690

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5852

34392

1.38

76.31

2.4

2.1

297.40

213.09

u/l

2.47

5438

31874

(3020682) Albumin/Creatinine [Ratio] in Urine

3827

36481

0.71

72.61

3.2

3.8

10.67

9.90

mg/mmol

0.41

2359

22898

(1761868) Lipid panel - Serum or Plasma

2196

23229

0.65

72.42

3.2

3.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1574

7215

1.66

68.82

1.6

1.5

—

(3019150) Specific gravity of Urine by Refractometry

3890

21711

1.41

67.24

5.3

4.8

1.02

kg/l

0.20

604

3606

(3012516) Albumin [Mass/volume] in Urine

3604

34370

0.71

67.19

2.8

3.2

516.21

399.50

mg/l

0.69

2253

22042

(3009508) Creatinine [Moles/volume] in Urine

3644

34589

0.71

65.66

2.7

3.1

6.87

6.88

mmol/l

0.04

2881

28121

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10657

86361

0.76

61.85

19.8

18.1

68.92

69.49

ml/min/173m2

1.94

8491

72195

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11317

90822

0.76

59.73

4.7

5.6

2.44

2.50

mmol/l

10.74

9858

80847

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1307

5917

1.67

59.57

1.9

1.6

1.78

1.61

6.81

1091

4822

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1651

7943

1.58

58.92

1.8

1.7

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

168

291

4.27

58.24

1.2

41.70

66.65

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1104

13006

0.60

56.92

1.2

15.58

15.29

u/ml

0.04

286

4307

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5143

30749

1.32

55.24

2.3

2.97

3.17

mg/l

7.02

4200

25922

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2442

24132

0.70

53.58

1.5

1.6

1.22

1.29

mmol/l

5.88

2120

19620

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7138

44797

1.29

52.85

4.7

4.4

54.92

86.05

ng/l

1.85

5699

35764

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

899

3803

1.78

52.06

1.2

1.3

—

(4035726) Immunohistochemistry procedure

750

9531

0.56

51.28

1.3

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6435

40141

1.28

48.64

2.5

2.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1280

13839

0.65

44.19

1.2

1.3

42.51

41.99

iu/ml

0.03

371

4255

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

247

665

2.75

44.01

1.1

—

3.34

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

213

528

2.99

43.97

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

636

8002

0.57

41.53

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

546

2139

1.90

40.32

2.4

2.1

29.63

32.90

umol/l

2.47

461

1844

(3015736) pH of Urine

6188

39095

1.25

39.49

4.2

4.0

5.94

5.83

0.78

125

1183

(3037467) Urinalysis macro (dipstick) panel - Urine

10435

69894

1.24

38.76

5.2

5.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

9483

62921

1.24

38.10

4.9

4.8

7.07

6.90

mmol/l

8.10

8932

59304

(3035350) Ketones [Presence] in Urine by Test strip

7489

48697

1.23

35.32

4.7

4.3

0.00

estimate

0.55

1294

10102

(3002256) Pathology report gross observation

1348

13691

0.70

32.65

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

708

8168

0.62

32.36

3.1

3.7

0.72

0.69

0.11

215

2900

(3017181) Myelocytes/100 leukocytes in Blood

809

9057

0.64

32.32

3.3

3.8

1.13

0.95

0.63

276

3396

(3021440) Promyelocytes/100 leukocytes in Blood

758

8604

0.63

32.24

3.3

3.8

0.15

0.10

0.91

230

2968

(3022145) Colonoscopy Study observation

1015

10779

0.67

31.27

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3906

23948

1.26

30.62

4.5

4.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

176

482

2.70

30.52

1.5

1.2

1.03

1.10

promille

0.25

149

353

(3009261) Glucose [Presence] in Urine by Test strip

7488

49172

1.21

30.17

4.6

4.4

0.00

estimate

1.60

1133

9047

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

102

202

3.72

29.89

1.3

1.2

48.29

21.25

—

(3029937) Albumin [Presence] in Urine by Test strip

4337

26965

1.24

29.89

5.2

4.7

0.00

estimate

1.34

1047

8688

(3026493) Urate [Moles/volume] in Serum or Plasma

3133

27787

0.79

28.87

2.4

3.0

7640.83

6691.65

umol/l

0.42

2494

23352

(3021601) Nitrite [Presence] in Urine by Test strip

7382

48548

1.20

28.77

6.0

5.8

0.00

estimate

0.50

1137

9217

(3037522) Nuclear Ab [Titer] in Serum

1038

10742

0.69

27.65

1.2

1.3

531.70

522.34

titre

0.06

212

2501

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3767

23239

1.24

27.46

4.4

4.3

236.41

426.98

ng/l

3.23

3407

20499

(3003694) ABO and Rh group [Type] in Blood

2480

22504

0.78

27.43

1.2

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

244

824

2.19

27.05

1.3

1.4

—

(3025159) Blasts/100 leukocytes in Blood

725

8006

0.65

26.97

3.3

3.8

0.06

0.42

3.77

196

2430

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1362

13404

0.72

26.88

4.2

5.0

34.94

33.84

2.49

784

8668

(3013512) EKG study

3982

34193

0.81

26.86

4.5

4.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

443

1851

1.78

26.74

1.1

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5688

36748

1.20

25.98

5.2

4.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

722

7912

0.66

25.85

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

8525

57138

1.19

25.75

19.7

21.0

1.38

1.42

inr

1.62

1953

15981

(3021589) Normoblasts [#/volume] in Blood

5048

42209

0.83

25.60

9.9

10.8

0.00

e9/l

0.88

3972

34309

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

137

366

2.76

24.98

1.1

42.34

46.07

mg/l

0.29

110

319

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1606

8983

1.34

24.87

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

104

238

3.22

24.70

1.6

1.5

—

(3003338) MCHC [Mass/volume]

10334

70559

1.19

24.66

27.7

25.2

330.19

330.65

g/l

5.35

10088

69756

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

198

645

2.27

23.97

2.4

2.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10067

68671

1.18

23.87

3.8

4.0

15.22

15.20

pmol/l

0.19

8780

60307

(3018095) Leukocytes [#/volume] in Urine

5994

39135

1.19

23.79

4.3

4.1

181.42

131.27

e6/l

1.58

4341

28893

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11196

87140

0.84

23.75

6.4

6.9

41.99

41.25

mmol/mol

9.82

9840

78234

(3000492) Spirometry study

660

7231

0.66

23.55

1.5

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

169

2702

0.45

23.40

1.6

1.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1442

8017

1.35

23.18

5.2

6.6

24.43

24.58

mmol/l

0.76

1382

7620

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

187

606

2.28

22.94

1.2

2.00

2.31

mmol/l

3.51

172

553

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

126

339

2.74

22.72

1.1

304.68

326.32

mg/l

0.21

107

300

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13205

92410

1.21

22.68

20.6

18.6

31.59

27.59

mg/l

27.16

11421

76839

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5799

47364

0.85

21.10

2.5

2.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11668

90177

0.85

20.77

4.7

5.4

6.20

6.13

mmol/l

5.48

10051

79326

(21494755) Public health laboratory ask at order entry panel

1649

0.35

20.71

1.2

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1701

0.36

20.64

1.4

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

5348

34902

1.18

20.51

3.7

3.5

128.01

110.70

e6/l

0.24

4134

27256

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

816

4207

1.45

20.43

1.9

2.2

948.77

538.07

ug/l

0.86

754

3969

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

329

4078

0.58

20.09

2.5

4.0

193.84

90.13

u/ml

1.19

305

3900

(3013139) Helicobacter pylori Ag [Presence] in Stool

548

6025

0.66

19.85

1.3

1.2

—

(4200892) Spirometry reversibility

702

7351

0.69

19.74

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

591

2875

1.53

19.73

1.4

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1439

13474

0.76

19.68

2.8

3.8

17.94

22.10

ug/l

0.33

1167

11265

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

590

2875

1.52

19.55

1.4

1.3

—

(40761535) Cells panel - Urine sediment

1673

9754

1.29

19.02

3.8

3.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

782

7983

0.71

19.01

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

116

338

2.53

18.03

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

189

3.08

17.60

1.8

1.6

—

(36304419) Bacteria [Presence] in Urine

4658

30410

1.17

17.06

3.5

3.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1964

11835

1.25

16.86

2.5

5.65

6.36

ug/l

1.13

1457

10009

(40768797) Stomach Pathology biopsy report

1530

13951

0.79

16.75

1.3

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

169

2401

0.51

16.68

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12027

84199

1.16

16.62

5.0

4.9

2.04

2.15

mu/l

2.10

10680

74463

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

851

8319

0.74

15.70

2.7

2.9

58.34

56.96

ml/min/173m2

0.52

340

3780

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

175

2402

0.53

15.48

1.2

—

(3014271) Vancomycin [Susceptibility]

229

936

1.81

15.08

3.3

3.1

—

(3052592) Norovirus Ag [Presence] in Stool

266

2.58

15.08

1.4

1.3

—

(3039000) Anion gap in Blood

520

2623

1.47

14.66

4.8

6.6

11.24

11.30

mmol/l

0.15

482

2341

(3018572) Chloride [Moles/volume] in Blood

520

2623

1.47

14.66

4.8

6.6

104.63

104.88

mmol/l

0.47

482

2341

(40768793) Breast Pathology biopsy report

136

1968

0.50

14.28

1.2

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

102

315

2.39

14.14

3.1

2.8

26.79

29.37

umol/l

1.39

235

(40760892) CBC W Ordered Manual Differential panel - Blood

5682

45568

0.87

14.13

4.7

6.1

—

(3006270) Folate [Moles/volume] in Blood

245

1052

1.72

13.69

1.2

309.55

312.53

nmol/l

0.07

189

781

(40768443) Skin Pathology biopsy report

470

4938

0.69

13.46

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

375

4110

0.66

13.42

1.2

1.3

278.09

255.30

u/ml

0.25

336

3722

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

105

337

2.30

13.39

1.5

88.97

105.42

umol/l

0.43

194

(3028026) IgM [Mass/volume] in Serum or Plasma

510

5274

0.70

13.36

1.9

1.83

1.41

g/l

1.34

422

4668

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2901

18541

1.18

13.31

3.3

3.2

2.80

2.58

e6/l

0.50

1555

10527

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

126

438

2.12

13.27

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1980

12255

1.21

12.97

3.3

3.1

238.09

273.68

ng/l

2.66

1822

11271

(3047181) Lactate [Moles/volume] in Blood

687

3734

1.37

12.76

4.6

5.7

1.43

1.35

mmol/l

0.89

620

3310

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

436

2.10

12.71

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

3790

24884

1.15

12.12

2.9

2.8

5.71

4.97

e6/l

2.79

3419

22218

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2746

22956

0.86

11.81

3.0

3.4

0.86

0.85

ug/l

0.13

1978

16856

(3007164) IgA [Mass/volume] in Serum or Plasma

1696

14766

0.83

11.73

1.5

2.86

2.71

g/l

1.14

814

8058

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

201

2450

0.60

11.64

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1370

0.47

11.56

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

3.68

11.50

1.1

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

179

2.67

11.45

15.1

11.1

0.68

0.65

mmol/l

0.33

165

(3003396) Base excess in Arterial blood by calculation

2289

14512

1.18

11.43

4.8

6.2

1.19

1.14

mmol/l

0.21

1721

11420

(3040151) Glucose [Moles/volume] in Capillary blood

314

1506

1.54

11.37

31.2

8.3

7.74

7.35

mmol/l

1.06

253

1240

(3024354) Oxygen [Partial pressure] in Venous blood

1616

9932

1.21

11.33

2.6

3.1

4.19

4.38

kpa

3.82

1533

9566

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

196

2376

0.60

11.12

1.5

1.7

12.42

12.40

mg/l

0.01

173

2148

(1001926) Buprenorphine [Presence] in Urine by Screen method

290

2.26

11.05

2.1

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3144

25911

0.87

11.05

2.3

2.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

222

2590

0.62

10.72

1.8

3.0

247.49

793.10

u/ml

2.33

193

2353

(3027945) Reticulocytes/100 erythrocytes in Blood

2425

15528

1.17

10.68

2.0

2.3

1.77

0.11

1973

13501

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3047

19857

1.15

10.64

3.0

1.57

1.37

e6/l

0.67

1686

11765

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

862

0.36

10.59

1.7

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1859

11670

1.19

10.36

5.1

6.8

119.99

119.09

g/l

1.13

1809

11340

(3000494) Fungus identified in Specimen by Culture

1250

11078

0.82

10.33

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

978

8883

0.80

10.18

1.7

1.9

180.46

171.68

ug/g

0.24

717

6794

(3019060) Gas panel - Arterial blood

1423

8729

1.21

10.16

3.8

4.4

—

(3030467) Casts [#/volume] in Urine by Automated count

4766

32081

1.13

10.08

3.5

0.60

0.50

e6/l

1.62

3687

25032

(3015171) Extractable nuclear Ab [Units/volume] in Serum

278

3049

0.66

10.07

1.2

0.46

1.11

u/ml

1.80

308

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

168

2061

0.59

10.05

1.2

3.56

5.05

u/ml

0.92

356

(3016502) Oxygen saturation in Arterial blood

2047

12991

1.18

10.03

4.9

6.4

94.97

95.20

0.70

1965

12446

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

358

3732

0.70

9.90

1.5

1.7

38.06

38.26

u/l

0.06

283

3115

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

203

2.43

9.82

1.2

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

5836

46029

0.90

9.82

4.8

5.7

60.57

59.24

12.72

5280

42385

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

113

1533

0.54

9.79

1.4

278.73

253.11

pmol/l

0.11

108

1482

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

167

2038

0.60

9.79

1.2

3.59

4.82

u/ml

0.22

236

(3004809) Band form neutrophils/100 leukocytes in Blood

177

2128

0.61

9.76

3.8

3.4

2.24

1.49

1.14

145

1831

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

271

2964

0.67

9.70

1.5

—

(3019069) Monocytes/100 leukocytes in Blood

5855

46148

0.90

9.69

5.0

6.1

8.93

8.95

0.22

5286

42446

(40768795) Lymph node Pathology biopsy report

1015

0.44

9.68

1.1

1.2

—

(3006504) Eosinophils/100 leukocytes in Blood

5825

45902

0.90

9.56

4.7

5.8

2.80

2.81

0.17

5260

42176

(40768800) Prostate Pathology biopsy report

238

2663

0.65

9.54

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

119

460

1.91

9.52

1.3

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1707

10730

1.19

9.35

4.4

5.7

1.55

1.38

mmol/l

7.03

1642

10374

(3013650) Neutrophils [#/volume] in Blood by Automated count

7281

56665

0.90

9.33

6.3

8.5

4.72

4.40

e9/l

16.25

6131

48784

(3036180) Methadone [Presence] in Urine

3.47

9.31

1.6

1.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

5961

46857

0.90

9.24

5.0

6.0

23.90

25.31

17.31

5388

43184

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2259

14541

1.16

9.23

4.9

6.2

4.94

5.07

kpa

7.95

2137

13734

(3027801) Oxygen [Partial pressure] in Arterial blood

2257

14531

1.16

9.19

4.9

6.2

11.35

11.74

kpa

3.18

2132

13714

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

161

2.56

9.16

2.5

2.3

139.45

128.94

nmol/l

0.37

138

(3024891) Influenza virus A+B Ag [Presence] in Specimen

424

2254

1.39

9.14

1.3

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1752

14892

0.85

9.10

2.7

3.8

246.48

250.67

u/l

0.50

1550

13920

(3009445) Proteinase 3 Ab [Units/volume] in Serum

489

4780

0.74

9.07

1.3

1.5

43.18

18.67

u/ml

—

110

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

360

3691

0.71

9.07

1.5

1.6

112.38

249.89

titre

2.70

175

(3006315) Basophils [#/volume] in Blood

6222

48761

0.90

9.03

4.5

5.4

0.04

e9/l

1.53

5136

41208

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

141

1754

0.59

8.96

1.2

2.09

6.39

u/ml

1.44

148

(3001604) Monocytes [#/volume] in Blood

6196

48554

0.90

8.96

4.5

5.4

0.64

e9/l

0.02

5116

41020

(3017354) Segmented neutrophils/100 leukocytes in Blood

1309

0.52

8.93

2.9

3.4

58.50

58.23

0.03

1064

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

133

1678

0.58

8.93

1.1

—

(3003181) Sodium [Moles/volume] in Urine

444

2388

1.38

8.93

1.4

1.3

61.10

61.26

mmol/l

0.03

357

1914

(3022096) Basophils/100 leukocytes in Blood

5671

44622

0.90

8.84

4.7

5.8

0.61

0.63

2.84

5108

40990

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

950

5671

1.24

8.82

2.8

3.8

24.01

24.15

mmol/l

0.58

906

5500

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

188

2169

0.63

8.73

1.2

27.20

41.01

u/ml

0.29

127

(3013115) Eosinophils [#/volume] in Blood

6417

50143

0.90

8.67

4.7

5.6

0.20

e9/l

0.18

5308

42924

(3011288) Drugs identified in Urine by Screen method

244

2.20

8.64

2.4

2.0

—

(3016879) Cocaine [Presence] in Urine

354

1.98

8.50

2.1

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

297

3109

0.70

8.47

1.4

21.80

15.92

iu/ml

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

350

1.98

8.43

2.7

2.0

58.46

53.85

umol/l

0.57

279

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2767

18180

1.14

8.42

1.7

1.9

29.82

30.23

2.37

2657

17639

(3019198) Lymphocytes [#/volume] in Blood

6358

49615

0.91

8.21

4.7

5.6

1.73

1.87

e9/l

4.79

5306

42873

(3018405) Lactate [Moles/volume] in Arterial blood

769

4529

1.26

8.06

3.2

3.8

1.51

1.40

mmol/l

1.20

756

4436

(3002032) Base excess in Venous blood by calculation

1875

12018

1.16

8.06

2.9

3.6

1.96

1.94

mmol/l

0.07

1573

10085

(3042631) Mycobacterium sp identified in Specimen

170

1965

0.63

8.00

2.5

2.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1878

12048

1.16

7.98

2.9

3.6

5.83

kpa

0.02

1796

11660

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

231

2502

0.67

7.95

1.5

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

141

1693

0.61

7.83

3.7

4.0

252.32

2171.25

iu/ml

1.13

247

(40757373) Influenza virus identified in Isolate

236

2.15

7.77

1.4

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

209

2295

0.66

7.73

2.3

2.2

207.29

211.85

0.31

189

2164

(3045142) Bone marrow Pathology biopsy report

1286

0.56

7.67

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

726

6602

0.80

7.67

2.4

2.7

10.78

10.71

g/l

0.13

620

5984

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

370

1.89

7.53

1.8

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

370

1.89

7.53

1.8

2.2

—

(3026782) Osmolality of Urine

3606

24241

1.12

7.43

3.1

3.2

548.70

536.05

mosm/kgh2o

3.07

3057

20728

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10971

77804

1.10

7.43

6.0

7.7

81.33

82.23

u/l

0.83

10012

72677

(4281824) Cell count and differential, peritoneal fluid

1030

0.52

7.33

1.2

—

(3023419) Bacteria identified in Sputum by Culture

170

1917

0.65

7.19

2.0

2.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

284

2.00

7.16

1.1

1.02

1.12

u/l

1.24

140

(3044640) Blood type and Crossmatch panel - Blood

4313

34125

0.90

7.11

2.4

2.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2151

14048

1.14

7.10

10.2

8.9

—

(3008898) HLA-B27 [Presence]

117

1429

0.60

7.02

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

380

1.84

6.98

2.2

1.4

—

(3028300) Cannabinoids [Presence] in Urine

386

1.83

6.94

2.3

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

471

2660

1.31

6.94

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

771

6877

0.82

6.81

1.4

—

(3027008) Opiates [Presence] in Urine

385

1.82

6.71

2.1

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

235

2454

0.70

6.70

1.8

2.0

87.68

87.61

0.02

219

2351

(3042111) Morphology [Interpretation] in Bone marrow Narrative

203

2172

0.68

6.63

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

124

2.49

6.62

1.0

1.2

22.58

50.42

2.50

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

471

4426

0.78

6.62

2.2

3.1

148.64

2438.81

u/ml

2.88

371

3767

(3017446) Testosterone [Moles/volume] in Serum or Plasma

644

5830

0.80

6.57

2.0

2.1

10.59

10.99

nmol/l

0.51

520

4922

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5715

39509

1.09

6.57

2.7

2.9

150.14

160.24

ug/l

1.40

4971

35313

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1050

0.55

6.55

2.0

3.6

60.44

54.59

u/ml

0.08

1024

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

181

875

1.52

6.54

1.3

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

472

2690

1.30

6.52

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1342

11353

0.86

6.51

4.3

6.1

11.30

11.81

mmol/l

1.52

1219

10611

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

178

859

1.53

6.48

1.3

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1234

0.59

6.48

1.4

1.6

0.70

0.86

g/l

0.89

932

(3039443) Prostate specific Ag panel - Serum or Plasma

1102

0.56

6.45

1.5

1.6

—

(3008295) Osmolality of Serum or Plasma

220

1112

1.46

6.41

1.3

274.21

275.34

mosm/kgh2o

0.24

161

814

(3051387) C reactive protein [Mass/volume] in Capillary blood

441

2497

1.30

6.41

4.1

3.8

30.73

29.97

mg/l

0.15

322

1655

(42529406) Shigella sp [Presence] in Stool by Culture

472

2698

1.29

6.39

1.2

—

(3016038) Potassium [Moles/volume] in Urine

177

858

1.52

6.33

1.1

32.72

35.35

mmol/l

0.79

138

712

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

248

2533

0.71

6.24

1.4

1.5

1.14

1.15

g/l

0.41

226

2374

(3012544) pH of Venous blood

1908

12467

1.14

6.24

2.9

3.6

7.40

7.39

—

(3044242) Glucose [Moles/volume] in Arterial blood

139

640

1.60

6.23

1.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

315

1.87

6.22

1.1

24.88

569.49

ng/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1190

0.59

6.17

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

1126

0.58

6.01

1.2

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1447

9309

1.15

5.93

2.4

35.55

39.78

u/l

0.51

1191

7886

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

779

0.51

5.91

1.1

1.2

71.40

84.82

u/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

243

2465

0.72

5.89

1.4

0.23

g/l

0.17

219

2304

(40761511) CBC panel - Blood by Automated count

12956

92937

1.09

5.87

19.7

18.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4804

33094

1.09

5.83

2.4

2.5

59.63

63.54

u/l

0.79

4369

30313

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

261

2611

0.73

5.80

2.1

3.61

3.66

g/l

0.19

241

2468

(3017143) Hepatitis C virus Ab [Presence] in Serum

753

6619

0.83

5.77

1.4

1.5

—

(3027944) Amphetamines [Presence] in Urine

373

1.76

5.70

2.2

1.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

158

1719

0.67

5.70

1.5

1.8

16.39

23.42

ug/l

3.45

152

1672

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

125

1422

0.64

5.62

1.2

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.23

5.52

1.0

1.2

50.25

44.93

0.16

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

128

1441

0.65

5.49

1.5

73.86

62.64

3.73

895

(3019550) Sodium [Moles/volume] in Serum or Plasma

13534

97384

1.09

5.37

25.0

22.5

139.57

139.48

mmol/l

2.29

13039

94716

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

3.79

5.32

1.1

1.2

4.44

2.10

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1256

8064

1.16

5.31

1.7

2.1

403.50

383.99

nmol/l

2.48

1076

7274

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1538

10023

1.14

5.24

1.8

2.0

0.19

0.20

g/l

0.84

1333

9203

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

214

1.96

5.16

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.41

5.16

1.1

1.3

13.55

14.75

0.07

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

129

1429

0.66

5.14

1.2

62.84

45.67

u/ml

0.49

162

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

514

4635

0.81

5.13

2.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

13542

97499

1.09

5.12

25.0

22.7

4.00

4.01

mmol/l

4.63

13023

94679

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

261

2552

0.75

5.03

2.5

2.6

1.77

1.83

mg/l

0.61

214

2245

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

888

0.58

5.01

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

589

0.49

4.97

1.3

1.1

0.26

1.28

u/ml

2.87

296

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

735

0.54

4.97

1.3

1.2

—

(3011412) CD3 cells [#/volume] in Blood

791

0.56

4.95

2.4

1.9

0.98

1.06

e9/l

0.46

723

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

862

5412

1.18

4.88

4.1

4.8

1.72

1.55

2.67

819

5093

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

219

1167

1.38

4.87

1.6

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12866

96414

0.92

4.84

10.0

11.6

22.82

23.93

u/l

2.88

12032

91827

(40768441) Liver Pathology biopsy report

602

0.50

4.82

1.2

—

(1002224) Polysomnography panel

164

1713

0.70

4.82

1.0

1.1

—

(3022621) pH of Urine by Test strip

1120

7202

1.15

4.66

4.0

3.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

146

1547

0.69

4.66

1.5

1.6

3.55

3.68

mg/l

0.06

113

1176

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

315

0.33

4.64

1.1

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

602

3680

1.21

4.61

3.6

3.2

0.79

0.82

nmol/l

1.19

466

2873

(3021879) Hepatitis B virus core Ab [Presence] in Serum

471

4234

0.81

4.60

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

230

1.85

4.52

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1089

0.64

4.51

1.3

12.39

11.84

u/l

0.13

865

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

915

0.61

4.48

1.4

1.8

4.37

4.71

mg/l

0.34

860

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

506

0.48

4.44

1.5

1.3

1.00

1.65

u/ml

0.33

295

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

232

1.84

4.41

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

845

5348

1.17

4.37

4.1

4.8

0.92

0.86

4.28

802

5024

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

166

0.22

4.34

1.0

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

141

1479

0.70

4.29

2.5

3.6

49.06

43.48

u/ml

0.10

130

1435

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

121

1302

0.68

4.24

1.3

0.17

0.31

nmol/l

1.28

(40765096) Chromosome analysis panel by Banding

343

0.38

4.23

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

332

0.38

4.22

1.1

1.4

151.45

178.00

pmol/l

0.29

332

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

451

4033

0.82

4.22

1.1

85.79

130.51

iu/ml

1.91

150

1318

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

110

1203

0.67

4.20

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

340

3132

0.79

4.20

1.4

—

(3045414) Leukocytes [Presence] in Urine

523

4602

0.83

4.15

2.2

2.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

121

1295

0.68

4.13

1.3

0.69

0.83

nmol/l

0.51

111

1229

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

749

0.59

4.12

3.4

3.7

—

(3020891) Body temperature

796

5041

1.17

4.10

4.0

4.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

294

0.35

4.08

1.1

0.13

1.61

u/ml

—

120

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

234

1.79

4.03

1.1

—

(21494434) Karyotype in Bone marrow

100

1103

0.66

4.00

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

506

0.51

4.00

1.1

1.0

0.95

2.79

u/ml

1.36

224

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

164

1655

0.73

3.99

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

510

3119

1.21

3.95

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

196

1921

0.75

3.94

2.2

3.2

5.03

4.46

e9/l

1.69

196

1915

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

231

1.78

3.91

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1026

0.66

3.90

1.1

1.58

1.57

g/l

0.08

908

(3010726) Horse dander IgE Ab [Units/volume] in Serum

381

0.44

3.88

1.1

0.23

0.79

u/ml

1.72

204

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

203

1974

0.75

3.87

1.3

41.36

41.34

u/l

0.00

174

1696

(3008401) Mugwort IgE Ab [Units/volume] in Serum

490

0.51

3.86

1.1

0.38

1.07

u/ml

1.15

199

(3041096) Erythrocytes [Presence] in Urine by Automated

3571

24665

1.08

3.86

4.4

4.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

349

0.42

3.85

2.6

1.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

355

1.62

3.83

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

1074

0.67

3.82

1.1

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

849

0.63

3.78

1.0

1.1

115.28

115.54

0.02

731

(3048929) Epstein Barr virus Ab [Presence] in Serum

139

1426

0.71

3.77

1.1

1.2

—

(3025130) Human papilloma virus identified in Specimen

466

0.50

3.76

2.3

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1060

0.67

3.74

1.1

—

(3045424) Erythrocytes [Presence] in Urine

174

1720

0.74

3.73

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

589

0.56

3.73

1.1

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

134

1378

0.71

3.70

4.4

3.7

—

(3000330) Specific gravity of Urine by Test strip

773

6518

0.86

3.69

4.1

4.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

779

0.62

3.66

1.2

1.4

6.48

7.20

g/l

0.96

544

(3028192) IgG subclass 2 [Mass/volume] in Serum

779

0.62

3.66

1.2

1.4

2.84

2.91

g/l

0.12

548

(3024139) IgG subclass 3 [Mass/volume] in Serum

779

0.62

3.66

1.2

1.4

0.41

0.46

g/l

0.47

550

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

886

0.64

3.64

1.0

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

259

2418

0.78

3.64

1.5

39.16

4.90

iu/ml

1.04

616

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

266

0.36

3.63

1.1

1.4

1.60

1.54

g/l

0.29

266

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

666

0.59

3.59

1.0

1.1

96.00

92.41

0.67

605

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

684

0.60

3.59

2.0

2.2

24.69

152.21

ug/min

2.77

163

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

3.58

0.0

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

952

0.66

3.56

1.3

1.2

62.38

47.84

u/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

133

1359

0.72

3.55

1.4

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1792

12058

1.10

3.53

4.6

3.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

967

0.67

3.51

1.1

1.2

4.00

5.35

u/ml

0.28

309

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

126

1296

0.71

3.50

1.8

2.1

679.20

1984.08

u/ml

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

975

0.67

3.50

1.2

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

975

0.67

3.50

1.2

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

975

0.67

3.50

1.2

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

159

1.90

3.50

3.2

2.9

0.41

0.51

u/field

0.28

159

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

240

1.72

3.48

1.2

143.62

134.74

nmol/l

0.15

176

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

800

5138

1.15

3.47

2.2

2.4

32.20

23.25

au/ml

0.56

232

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

4.90

3.45

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

143

1436

0.73

3.44

1.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

576

4934

0.85

3.41

2.2

2.6

0.37

0.35

u/ml

0.96

313

2809

(4062490) Immunoglobulin typing, IgG

782

0.64

3.39

1.2

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

544

0.57

3.39

1.1

1.4

3.89

3.91

—

128

(4146454) Self-monitoring of blood glucose

138

1390

0.73

3.39

2.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

169

0.30

3.38

14.3

12.7

5.93

5.38

mmol/l

—

169

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

110

1148

0.70

3.35

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

806

0.65

3.34

1.3

1.2

8.09

7.98

mmol/l

0.10

636

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

113

1173

0.71

3.34

1.4

1.3

121.14

125.14

u/ml

0.15

256

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

244

0.36

3.34

1.2

1.0

0.16

0.28

u/ml

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

597

0.59

3.33

1.0

1.1

100.12

90.11

u/l

0.35

521

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

597

0.59

3.33

1.0

1.1

39.90

29.51

u/l

0.49

517

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

161

1579

0.75

3.32

1.2

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

587

0.59

3.32

1.1

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

392

3458

0.83

3.28

1.6

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

163

1.85

3.27

2.2

2.1

—

(3021788) Differential panel - Synovial fluid

221

2073

0.78

3.27

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

201

1907

0.77

3.26

2.5

3.2

—

(3011985) Renin [Units/volume] in Plasma

118

1210

0.71

3.25

1.2

1.4

50.61

58.52

mu/l

0.24

1063

(3014133) Dog dander IgE Ab [Units/volume] in Serum

314

0.44

3.25

1.1

0.53

2.25

u/ml

—

150

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

328

2941

0.82

3.25

1.8

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

149

1470

0.74

3.21

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

926

6044

1.13

3.19

2.4

2.6

1.20

1.15

0.99

920

6012

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

485

0.56

3.14

1.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

437

0.54

3.13

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

309

0.45

3.13

2.6

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

256

0.40

3.09

2.6

2.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

171

1642

0.76

3.06

1.3

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

452

0.55

3.05

1.1

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

452

0.55

3.05

1.1

1.7

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

3.03

0.0

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

936

0.69

3.02

1.1

1.2

4.73

4.54

u/ml

0.06

397

(1617658) Protocol used for examination of sentinel lymph nodes

680

0.64

3.02

1.1

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

221

2049

0.79

3.00

1.2

1.1

66.67

148.92

titre

3.22

148

(3001186) Copper [Moles/volume] in Serum or Plasma

131

1.91

3.00

1.2

1.1

15.53

16.66

umol/l

0.78

120

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

986

0.70

2.99

1.5

1.8

164.36

190.60

pmol/l

2.63

898

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

163

1.80

2.99

2.2

2.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

196

1.73

2.97

1.2

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

356

1.53

2.96

1.1

—

(3047189) Immunofixation for 24 hour Urine

640

0.63

2.94

1.3

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1397

9375

1.10

2.94

2.8

3.6

90.55

99.52

ng/l

3.33

1115

7759

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

172

1640

0.77

2.94

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

839

6919

0.88

2.93

2.5

2.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

932

6127

1.12

2.88

3.6

4.3

46.22

46.15

0.03

919

6050

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

300

1.57

2.88

1.1

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

984

6490

1.12

2.88

3.4

2.9

0.43

0.30

e6/l

1.11

967

6375

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

195

1115

1.29

2.87

1.8

1.6

28.44

25.90

u/ml

0.33

226

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

112

1129

0.73

2.83

1.2

1.3

241.58

273.47

pmol/l

0.62

943

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

569

0.62

2.80

2.4

1.8

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.24

2.79

1.4

1.1

—

mmol/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

456

0.58

2.75

1.2

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

152

1458

0.76

2.74

2.0

2.4

0.88

1.12

g/24h

0.58

686

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

380

0.54

2.73

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

464

0.58

2.72

1.1

—

(3012565) Volume of 24 hour Urine

519

0.61

2.72

2.3

2.2

1735.00

1791.42

0.12

434

(3017817) Protein [Mass] in Urine collected for unspecified duration

111

1112

0.73

2.71

1.9

2.0

—

0.89

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

902

5942

1.12

2.71

2.4

2.5

0.68

0.66

0.91

897

5915

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

401

3462

0.85

2.69

1.0

1.1

—

(4034850) Laboratory test

496

3143

1.16

2.67

12.9

13.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

452

0.58

2.67

2.6

2.5

43.57

36.34

1.52

275

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

498

0.60

2.67

2.0

2.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

281

1693

1.22

2.66

1.8

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

257

2306

0.82

2.64

1.4

1.5

30.91

31.33

g/l

0.23

227

2044

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

113

1123

0.74

2.63

1.3

—

nmol/l

—

(3026470) Cobalt [Mass/volume] in Blood

893

0.71

2.63

1.8

1.9

2.32

4.19

ug/l

3.06

811

(3017732) Neutrophils [#/volume] in Blood

771

6343

0.89

2.62

3.3

6.62

5.70

e9/l

0.41

520

4585

(3037692) Legionella sp identified in Specimen by Organism specific culture

393

0.56

2.61

1.7

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.32

2.61

1.1

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

777

0.69

2.58

1.3

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

102

1.95

2.56

1.1

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

120

1172

0.75

2.50

1.1

1.2

65.90

61.39

u/l

0.27

1045

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

515

0.63

2.48

2.3

1.9

444.45

504.25

e6/l

0.40

437

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

143

0.36

2.45

1.0

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

102

1016

0.74

2.44

1.2

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

611

0.66

2.44

2.0

2.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

240

0.46

2.44

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

240

0.46

2.44

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

240

0.46

2.44

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

240

0.46

2.44

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

152

1432

0.78

2.43

1.2

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

410

0.59

2.39

1.9

1.8

977.82

1669.67

u/ml

1.57

396

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

859

0.72

2.38

1.2

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

112

1095

0.75

2.38

1.4

1.5

15.20

27.11

7.92

680

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

108

1061

0.75

2.37

1.1

1.2

260.26

290.90

u/ml

0.56

631

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

702

4600

1.13

2.35

1.2

1.3

48.02

62.08

au/ml

0.80

244

(3000012) Reticulocyte production index

242

2156

0.82

2.35

2.0

2.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

155

1449

0.78

2.35

1.3

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1163

7831

1.10

2.34

2.8

3.3

127.62

125.78

g/l

2.14

1137

7631

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

489

0.63

2.33

2.3

1.9

0.21

0.24

e9/l

0.77

437

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

2.30

0.0

2.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

2.29

0.0

12.5

—

207.59

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

774

0.71

2.27

1.3

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.00

2.26

1.1

1.0

—

(3010813) Leukocytes [#/volume] in Blood

13611

98762

1.06

2.26

29.1

27.6

7.23

6.99

e9/l

13.12

12957

95041

(3006184) Hemoglobin [Mass/volume] in Capillary blood

463

2961

1.15

2.26

2.1

2.3

127.61

125.68

g/l

0.85

369

2164

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.03

2.26

1.1

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

538

0.65

2.25

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

13604

98716

1.06

2.24

29.1

27.6

37.90

38.97

33.68

11790

90436

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

537

0.66

2.23

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

537

0.66

2.23

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

401

0.60

2.21

3.2

2.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

534

0.66

2.18

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

534

0.66

2.18

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

154

1426

0.79

2.18

1.3

1.4

—

(3042936) Bacteria identified in Isolate by Culture

2023

15778

0.93

2.17

1.9

2.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

533

0.66

2.17

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

268

2343

0.84

2.16

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

161

1481

0.80

2.15

1.3

1.4

6.30

6.40

mmol/l

0.18

137

1376

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

221

1966

0.82

2.15

1.3

1.4

—

(3035941) MCH [Entitic mass]

13603

98746

1.05

2.13

29.0

27.4

30.44

30.43

0.34

13149

96679

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

137

1.72

2.11

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

155

1428

0.80

2.11

1.3

1.4

—

(3024928) Oxygen saturation in Venous blood

387

2457

1.16

2.11

1.8

2.6

—

(3026361) Erythrocytes [#/volume] in Blood

13603

98753

1.05

2.11

29.1

27.6

4.24

4.35

e12/l

111.02

12934

94998

(3003740) Influenza virus B Ag [Presence] in Specimen

476

0.65

2.10

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

340

0.58

2.10

1.4

1.3

54.19

34.76

u/l

0.83

274

(3007461) Platelets [#/volume] in Blood

13600

98736

1.05

2.09

29.1

27.6

236.68

238.12

e9/l

1.58

12991

95454

(3024731) MCV [Entitic volume]

13602

98751

1.05

2.09

29.0

27.5

92.01

91.89

1.97

13153

96686

(3042517) Benzodiazepines panel - Urine

4.41

2.09

5.2

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

13603

98764

1.05

2.08

29.3

27.8

127.89

131.34

g/l

125.64

13128

96717

(3034426) Prothrombin time (PT)

215

0.48

2.08

1.1

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

161

1473

0.80

2.07

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

155

1424

0.80

2.07

1.3

1.4

—

(3004775) Volume in Urine collected for unspecified duration

108

1036

0.76

2.05

2.0

2.2

669.75

649.20

0.16

661

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.12

2.04

1.5

1.7

28.19

17.30

umol/l

2.30

(3020650) Glucose [Presence] in Urine

202

0.47

2.00

2.8

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

3687

26007

1.05

1.98

3.8

4.1

80.82

82.62

3.92

3570

25420

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2148

16667

0.94

1.98

1.2

1.72

1.77

u/ml

0.05

477

3960

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

149

1366

0.80

1.97

3.3

3.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

200

0.48

1.95

4.8

7.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

127

0.40

1.95

1.3

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

742

0.73

1.93

1.1

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

282

1.46

1.92

1.2

1.5

16.98

16.74

pmol/l

0.10

224

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.24

1.92

1.3

1.2

—

(3004451) EKG impression Narrative

714

0.73

1.89

1.2

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

142

1.66

1.89

1.2

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

191

1697

0.82

1.88

1.2

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

542

0.69

1.88

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

226

0.52

1.88

1.2

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

472

0.67

1.88

1.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

2.38

1.88

1.2

1.1

0.11

0.10

umol/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

245

0.54

1.87

5.7

7.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

326

2767

0.86

1.87

1.6

23758.46

14628.52

e6/l

1.46

227

1965

(3024932) HLA-DR beta [Type]

149

0.44

1.87

1.1

—

(3048879) Bone marrow aspiration report

436

0.66

1.86

1.1

1.5

—

(3025577) Chromium [Mass/volume] in Blood

862

0.76

1.85

1.9

2.0

1.61

2.34

ug/l

2.29

714

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

201

1771

0.83

1.82

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

607

0.71

1.82

1.0

—

(3019977) pH of Arterial blood

133

776

1.26

1.80

2.1

2.4

7.42

0.11

317

(3018133) Calcium [Moles/volume] in Urine

101

0.36

1.79

1.6

1.34

2.68

mmol/l

—

(3010838) Calcium [Moles/time] in 24 hour Urine

183

1623

0.83

1.79

1.6

1.7

4.25

4.48

mmol/24h

0.43

136

1347

(44816559) Phosphatidylethanol [Mass/volume] in Blood

173

1041

1.22

1.78

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

730

0.74

1.76

1.2

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

745

4993

1.10

1.73

1.9

1.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

101

1.75

1.72

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.02

1.71

3.6

7.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.62

1.70

1.2

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.39

1.70

1.2

1.1

—

(3016750) Collection duration of Urine

716

0.75

1.69

2.0

494.33

498.71

min

0.11

502

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2747

21060

0.95

1.68

1.6

1.7

1.73

1.56

mg/l

1.12

2122

16597

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

110

0.40

1.67

1.8

1.4

—

(40768806) Pleura Pathology biopsy report

200

1746

0.84

1.67

1.4

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

316

2018

1.15

1.67

1.9

1.78

1.70

mmol/l

0.67

310

1966

(3007853) Bacteria identified in Skin by Aerobe culture

1801

12515

1.06

1.67

1.7

1.8

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.67

1.66

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

344

0.64

1.65

2.0

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

730

0.75

1.65

1.2

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

139

0.48

1.65

1.3

1.7

—

(3036048) Francisella tularensis Ab [Titer] in Serum

177

0.50

1.64

1.2

—

1475.56

—

(3042733) HLA Ab [Presence] in Serum

142

0.47

1.64

7.2

4.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

203

1766

0.84

1.63

1.3

1.4

—

(3024471) HLA-A [Type]

157

0.47

1.63

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

334

0.64

1.63

1.0

1.1

9.35

13.06

iu/ml

—

(3014051) Protein [Presence] in Urine by Test strip

347

2897

0.88

1.62

2.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

819

0.77

1.62

1.1

—

(3017509) Phencyclidine [Presence] in Urine

3.15

1.59

1.5

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

557

0.72

1.58

1.2

1.4

2.57

2.53

0.02

463

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

641

0.74

1.58

1.2

1.4

58.89

66.42

0.82

519

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

188

1157

1.20

1.58

2.5

2.3

2.16

2.24

u/field

0.08

392

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

268

0.60

1.58

2.7

2.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

331

0.64

1.57

1.1

1.03

1.11

ratio

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

691

0.75

1.57

1.6

1.5

4.16

7.18

u/l

1.13

547

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

117

1069

0.80

1.57

1.1

57.72

430.34

iu/ml

0.83

199

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

1.56

0.0

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

748

0.76

1.56

3.0

2.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

580

4687

0.91

1.55

2.5

3.1

50.21

83.34

mg/l

1.67

455

3791

(3000034) Microalbumin [Mass/volume] in Urine

117

1067

0.80

1.55

2.6

3.1

36.73

42.60

mg/l

0.20

792

(3037121) Protein [Mass/volume] in Urine

503

4092

0.90

1.53

2.4

2.8

0.31

g/l

0.00

167

1630

(3013707) Erythrocyte sedimentation rate by Westergren method

9935

71847

1.04

1.53

3.8

4.4

15.84

15.41

mm/h

1.57

8797

65133

(3012441) Differential panel - Pleural fluid

202

1746

0.85

1.53

1.4

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

292

0.63

1.51

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

694

0.76

1.50

1.0

1.1

3.41

3.90

u/ml

0.11

154

(40757494) Bilirubin.total [Moles/volume] in Blood

109

638

1.26

1.49

2.4

2.0

18.72

28.12

umol/l

0.65

(1761482) Bacteria [#/volume] in Urine by Culture

477

3885

0.90

1.49

4.8

4.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

580

4675

0.91

1.48

2.5

3.1

50.81

50.48

mg/l

0.01

460

3778

(3006442) Creatine [Moles/volume] in Serum or Plasma

617

0.75

1.48

2.1

1.8

87.46

98.18

umol/l

1.26

617

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

951

6496

1.08

1.47

6.4

8.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

198

1708

0.85

1.47

1.4

0.86

0.81

nmol/l

0.33

162

1399

(3028433) Virus identified in Specimen by Culture

334

0.66

1.47

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

219

1.44

1.46

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2043

15713

0.95

1.43

3.7

5.2

1.03

1.04

mmol/l

2.00

1776

14302

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

400

3278

0.89

1.42

1.7

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7680

55343

1.03

1.41

4.4

6.0

12.73

12.36

umol/l

1.20

7047

52409

(3006462) Nitrate [Presence] in Urine

553

0.74

1.41

4.4

4.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

111

657

1.24

1.40

2.4

2.0

1.95

2.39

u/field

0.34

439

(3023323) Follitropin [Units/volume] in Serum or Plasma

661

0.77

1.40

1.4

50.86

34.84

iu/l

2.11

557

(3027273) Bicarbonate [Moles/volume] in Venous blood

971

6655

1.08

1.39

3.0

3.5

25.30

25.12

mmol/l

0.85

933

6470

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

493

0.73

1.39

5.6

5.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.23

1.38

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.05

1.38

1.2

1.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

194

0.57

1.38

1.5

1.6

—

(3022313) Gas panel - Capillary blood

712

5663

0.92

1.38

3.3

3.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

237

2003

0.87

1.37

1.3

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

212

0.59

1.37

3.9

2.5

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

1.36

0.0

1.1

—

15.48

—

(3027035) Albumin [Mass/time] in 24 hour Urine

110

0.47

1.34

1.6

1.3

—

743.82

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

640

0.77

1.34

4.4

4.8

68.78

134.60

u/ml

0.51

182

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

134

1184

0.83

1.34

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.95

1.32

1.1

1.0

—

(40768446) Kidney Pathology biopsy report

255

0.63

1.32

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

308

0.67

1.32

1.3

1.5

0.15

0.14

nmol/l

0.13

222

(3026726) Creatinine [Moles/volume] in Specimen

0.45

1.31

3.0

2.5

151.33

431.39

umol/l

—

(3022689) Creatine [Moles/volume] in Urine

280

0.66

1.29

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

105

1.61

1.29

1.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

568

4544

0.92

1.28

2.5

3.0

2.86

3.53

ratio

0.36

328

(3010144) Erythrocytes [#/volume] in Synovial fluid

125

1105

0.83

1.27

1.3

1.4

205382.58

184972.06

e6/l

0.09

757

(40761536) Microorganisms panel - Urine sediment

1110

8655

0.94

1.27

4.9

4.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

181

1549

0.86

1.26

1.2

1.3

553.59

440.35

u/l

0.35

163

1461

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

274

1778

1.13

1.23

1.1

10.12

11.88

u/ml

—

(3023520) Reticulocytes [#/volume] in Blood

1682

11784

1.05

1.23

2.1

2.5

65.70

67.53

e9/l

1.25

1252

9006

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

159

0.55

1.22

4.9

7.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

140

0.52

1.22

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

240

0.64

1.21

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

198

1.41

1.19

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

1.19

0.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

274

0.67

1.18

1.3

1.5

14.88

9.36

—

138

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

1.18

0.0

1.0

—

0.11

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.92

1.18

1.1

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

453

0.75

1.18

1.1

—

(40762814) Titanium [Mass/volume] in Blood

256

0.66

1.18

2.0

2.1

2.84

3.53

ug/l

1.17

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

1.17

0.0

1.4

—

(3014891) Appearance of Pleural fluid

256

1.35

1.15

1.3

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

366

2969

0.90

1.13

1.9

2.2

106.45

99.97

ug/min

0.11

183

1677

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

182

0.60

1.12

1.1

—

(3015183) Erythrocyte sedimentation rate

200

0.62

1.12

1.1

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

121

1057

0.84

1.12

1.5

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

148

926

1.18

1.12

1.3

257.39

378.13

titre

0.44

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

788

5414

1.07

1.11

2.0

—

(3009871) Measles virus Ab [Titer] in Serum

121

0.55

1.10

1.6

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

145

1245

0.85

1.10

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

260

0.68

1.09

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

242

2001

0.89

1.07

1.4

1.5

6036.06

2283.31

e6/l

0.92

179

1441

(3036670) Protein [Mass/volume] in Synovial fluid

420

0.75

1.07

1.1

1.2

38.74

40.06

g/l

0.33

206

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

111

1.52

1.06

1.7

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

813

5603

1.07

1.06

1.8

1.9

2.81

2.27

ug/l

0.38

638

4841

(3008037) Lactate [Moles/volume] in Venous blood

419

3361

0.91

1.05

3.4

3.6

1.76

1.65

mmol/l

1.53

410

3288

(40760888) Immunoglobulin light chains.free panel - Serum

438

3505

0.92

1.04

2.6

3.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

143

899

1.17

1.04

1.3

28.00

68.29

titre

—

(3045788) Cell count panel - Pleural fluid

182

1527

0.87

1.02

1.4

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

192

1.38

1.02

1.2

1.1

1592.89

1651.17

miu/ml

0.10

192

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.80

1.01

1.2

1.1

123.80

208.24

pmol/l

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

1.00

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

295

1.30

1.00

1.2

1.3

—

(3036489) Thrombin time

415

3320

0.92

1.00

1.7

1.8

21.50

22.17

0.78

371

3002

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7312

52863

1.03

0.99

3.3

3.1

53.80

57.08

u/l

1.89

6440

47389

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

162

1.41

0.99

1.0

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

193

0.65

0.99

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1617

11391

1.05

0.99

2.3

2.6

10.12

9.88

umol/l

0.14

1325

9892

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.63

0.98

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

643

0.81

0.98

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

643

0.81

0.98

1.4

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

222

1830

0.89

0.96

1.4

1.5

48512.53

64459.03

e6/l

0.47

135

1077

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

1.51

0.96

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

200

1656

0.89

0.94

1.3

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

200

1656

0.89

0.94

1.3

1.4

—

(3035880) pH of Pleural fluid

106

919

0.85

0.94

1.1

1.3

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

155

0.62

0.94

1.1

1.4

—

10.83

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

460

0.78

0.94

1.1

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

402

3207

0.92

3.5

3.7

8.25

7.70

mmol/l

2.67

396

3140

(3024869) Neuronal Ab [Presence] in Serum

215

1.33

0.92

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.49

0.91

4.2

4.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

203

1.34

0.91

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

375

0.76

0.90

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.96

0.90

1.1

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

116

0.57

0.89

1.6

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

274

0.72

0.89

1.1

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

206

1347

1.12

0.89

1.5

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

455

0.79

0.87

1.1

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

1.46

0.86

1.1

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

429

0.79

0.85

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

569

1.19

0.85

1.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1110

7783

1.05

0.85

5.7

7.4

1.44

1.33

3.83

1103

7715

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4326

32434

0.97

0.85

4.5

4.9

21.72

22.54

3.00

2142

17918

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

203

0.69

0.85

1.6

1.7

10.37

9.97

ug/l

0.14

203

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

502

1.20

0.85

1.1

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

104

0.56

0.84

5.8

4.6

35.50

51.95

ug/min

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.79

0.84

1.2

1.0

—

(3017569) Oxygen content in Arterial blood

677

0.83

2.4

2.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

158

0.65

0.82

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

201

0.69

0.81

1.2

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.81

0.0

8.9

—

39.83

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

438

1.21

0.81

2.6

2.7

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.81

0.0

7.8

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

0.80

0.0

1.1

—

165.80

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

657

0.84

0.79

1.2

93.31

94.70

u/l

0.04

568

(3011335) Digoxin [Mass/volume] in Serum or Plasma

165

0.67

0.79

2.7

2.4

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.78

0.0

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.78

0.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.78

0.0

1.1

—

8.20

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

695

0.84

0.77

1.1

1.2

74.00

129.38

titre

—

130

(3027923) C peptide [Moles/volume] in Serum or Plasma

481

1.19

0.77

1.4

1.2

1.09

1.16

nmol/l

0.25

362

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

148

1227

0.88

0.76

1.2

1.3

22.81

12.15

u/l

1.86

131

1122

(3009015) Lactate [Moles/volume] in Synovial fluid

137

0.64

0.75

1.2

6.60

6.15

mmol/l

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

137

0.64

0.75

2.1

1.5

58.12

56.51

pmol/l

0.03

103

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

197

1604

0.90

0.74

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.55

0.74

1.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

862

6638

0.95

0.73

6.2

7.5

24.11

24.37

mmol/l

1.21

800

6310

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1102

7764

1.05

0.72

5.7

7.5

0.70

0.66

2.25

1092

7697

(3051593) INR in Capillary blood by Coagulation assay

832

0.86

0.72

7.3

12.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

212

0.73

0.71

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

178

0.70

0.71

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

195

0.72

0.71

1.1

1.2

—

(3010421) pH of Blood

480

3310

1.07

0.70

3.9

4.2

7.42

0.53

407

3017

(3030313) Adrenal Ab [Titer] in Serum

1.71

0.70

1.0

—

(3024263) Appearance of Synovial fluid

582

1.16

0.69

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

765

0.86

0.69

1.1

1.2

243.82

191.00

miu/ml

0.28

191

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.58

0.69

1.3

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

116

0.63

0.68

1.2

3.2

—

(3032057) Clostridioides difficile [Presence] in Stool

326

1.22

0.68

1.5

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

198

1318

1.10

0.68

3.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

121

1006

0.88

0.67

1.2

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

212

1708

0.91

0.67

2.1

2.2

35.77

27.50

mg/l

0.89

419

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

150

0.69

0.67

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

150

0.69

0.67

1.3

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

478

0.83

0.67

1.4

1.5

5.25

6.22

u/l

1.17

385

(3032773) Endomysium IgG Ab [Titer] in Serum

578

1.16

0.66

1.1

—

(3051651) Icteric interference index of Serum or Plasma

109

702

1.14

0.66

3.6

3.8

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

283

0.78

0.65

1.1

1.2

1.56

1.49

mmol/l

0.12

175

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

975

6874

1.04

0.64

4.8

6.0

24.76

24.81

mmol/l

0.15

961

6791

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

595

0.85

0.64

4.3

3.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

371

0.81

0.64

1.4

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

224

0.75

0.64

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

136

1117

0.89

0.63

1.3

1.4

13.63

13.42

u/l

0.15

128

1066

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

164

1.30

0.63

1.1

1.3

94.07

117.26

ug/l

0.40

102

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.58

0.63

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

316

1.21

0.63

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

0.57

0.63

1.2

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

273

0.78

0.63

4.7

6.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

190

0.73

0.63

1.2

85.00

78.37

—

(3000991) Gas panel - Venous blood

1444

10270

1.04

0.62

5.1

6.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5461

40672

0.98

0.62

4.7

5.7

6.36

4.59

ug/l

0.73

4619

35693

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.61

0.0

2.3

—

2.57

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.61

0.0

9.1

—

44.14

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

(3049717) Cytology report of Urine Cyto stain

732

5626

0.95

0.61

2.7

2.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

385

0.82

0.61

1.8

1.9

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.61

0.0

1.1

—

0.21

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

255

2026

0.92

0.61

2.7

2.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

189

0.74

0.61

1.2

1.1

76.50

81.39

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

638

0.86

0.60

1.2

33.53

28.83

u/l

0.24

540

(3025549) Creatine [Moles/time] in 24 hour Urine

1.39

0.60

1.3

1.4

—

(36303858) Crystals [Presence] in Urine

0.00

0.60

0.0

1.2

—

(3044889) 12 lead EKG panel

9232

68390

0.98

0.59

4.6

—

(3019225) pH of Specimen

1615

12209

0.97

0.59

4.2

4.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

343

0.81

0.59

1.1

1.2

140.96

155.99

mmol/24h

0.46

343

(3013293) Extractable nuclear Ab [Presence] in Serum

120

0.67

0.59

1.8

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

680

4769

1.05

0.58

2.7

3.1

4.25

4.29

pmol/l

0.62

566

4078

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.57

1.0

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2269

17054

0.97

0.57

2.2

2.6

20.46

20.95

0.86

1677

14344

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

712

0.88

0.56

1.0

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.49

0.56

1.8

1.3

1.17

1.06

u/field

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

464

1.16

0.56

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

169

0.74

0.55

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

181

1216

1.09

0.55

2.5

2.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

326

2554

0.94

0.55

1.3

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

110

721

1.12

0.54

1.4

1.7

—

4.00

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

618

4747

0.95

0.53

3.5

4.2

24.93

24.91

mmol/l

0.07

529

4279

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

473

0.85

0.53

1.4

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

305

0.82

0.52

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

111

1.32

0.51

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

527

3689

1.05

0.51

3.4

3.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2679

19297

1.02

0.50

2.1

2.5

10.99

11.71

umol/l

6.27

2329

17699

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

586

1.13

0.50

1.6

1.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

112

739

1.11

0.50

1.1

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

345

2686

0.94

0.50

1.3

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

138

1113

0.91

0.50

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

131

1059

0.91

0.50

1.2

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

438

0.85

0.49

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.64

0.49

1.1

1.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.63

0.49

1.0

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

492

0.87

0.48

1.0

271.90

290.64

mg/l

1.30

435

(3006576) Bicarbonate [Moles/volume] in Blood

437

0.86

0.48

3.8

6.5

24.39

24.77

mmol/l

0.32

391

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

584

4108

1.05

0.48

1.8

2.2

36.65

36.88

g/l

0.36

439

3431

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

404

0.85

0.47

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

404

0.85

0.47

1.1

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

241

1892

0.93

0.47

1.5

1.6

3.72

4.70

iu/l

0.87

535

(3000285) Sodium [Moles/volume] in Blood

179

1.23

0.47

1.3

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.68

0.46

4.6

4.1

—

(3019174) dRVVT (LA screen)

0.59

0.46

1.0

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

0.59

0.46

1.0

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.59

0.46

1.2

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.59

0.46

1.2

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.36

0.46

2.0

1.8

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

410

0.86

0.45

5.7

5.2

61.29

72.28

1.29

320

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1397

10002

1.03

0.44

3.2

3.9

1.23

mmol/l

0.78

1128

8652

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

170

0.78

0.44

1.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

202

0.80

0.43

1.3

1.4

82.12

74.95

0.47

171

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

226

0.81

0.43

1.4

123.55

126.85

ng/l

0.06

226

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

153

0.77

0.43

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.60

0.43

1.2

1.3

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.42

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.42

0.0

2.8

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.53

0.41

1.4

501.80

383.16

nmol/l

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

2.1

—

2.22

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.41

0.0

1.8

—

2.15

—

(40758558) Short blood count panel - Blood

3434

24864

1.02

0.41

5.3

6.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

484

0.88

0.41

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.47

0.40

1.0

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.47

0.40

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.40

0.0

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

103

1.28

0.40

1.0

1.2

1.70

1.71

umol/24h

0.02

103

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

159

0.78

0.39

1.1

1.2

14.89

17.35

u/l

—

108

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

126

0.76

0.39

1.0

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

369

1.13

0.38

1.3

1.4

76.74

60.46

4.84

317

(37021550) Renin [Units/volume] in Plasma --upright

222

0.83

0.38

1.3

36.72

85.66

mu/l

2.02

156

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3909

28363

1.02

0.37

2.8

3.1

35.50

37.07

u/l

0.58

3587

26545

(3017315) Amylase [Enzymatic activity/volume] in Urine

510

0.89

0.36

1.2

171.91

328.99

u/l

1.80

472

(3035933) Granulocytes/100 leukocytes in Blood

108

0.75

0.36

1.7

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.30

0.36

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.30

0.36

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.30

0.36

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

192

1500

0.94

0.36

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5525

40943

0.99

0.35

3.0

3.3

2245.22

1975.86

ng/l

2.83

4651

35812

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.38

0.35

1.5

1.6

—

(3003129) Base excess in Capillary blood by calculation

321

0.87

0.34

1.5

1.9

1.10

0.69

mmol/l

0.19

301

(3036525) Urea [Moles/time] in 24 hour Urine

0.67

0.33

2.0

3.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

626

4455

1.03

0.33

1.8

2.4

1.28

1.13

g/l

0.31

476

3691

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

242

0.85

0.33

1.3

1.1

256.41

280.60

pmol/l

0.17

168

(3002331) Protein [Mass/volume] in Peritoneal fluid

249

1.15

0.33

1.3

20.27

50.96

g/l

0.77

204

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

133

1.22

0.33

1.2

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

487

3452

1.04

0.33

2.6

3.1

24.88

24.97

mmol/l

0.19

470

3378

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

273

0.86

0.32

1.6

1.5

0.46

0.40

ug/l

0.24

147

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

118

805

1.08

0.32

1.2

1.12

1.46

nmol/l

4.42

106

729

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

155

1069

1.07

0.31

1.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

201

0.84

0.31

1.2

1.3

37.15

395.96

u/l

0.87

139

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.32

0.31

1.3

1.1

212.14

269.42

nmol/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

141

1.20

0.31

1.5

1.7

39.87

47.16

umol/l

0.79

141

(40767503) Oxygen content in Capillary blood by calculation

392

2772

1.04

0.30

2.5

2.6

16.29

15.69

1.95

192

1495

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

307

2353

0.96

0.30

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

155

1070

1.06

0.30

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

525

1.09

0.29

1.4

13.72

14.79

umol/l

0.51

489

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

617

1.08

0.29

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

617

1.08

0.29

1.2

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

199

0.85

0.28

1.0

1.3

109.41

114.62

0.40

172

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.77

0.28

1.2

1.1

10.89

11.40

u/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

346

0.89

0.27

1.6

1.7

2770.60

15973.03

e6/l

1.57

200

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

135

0.82

0.27

1.0

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.26

0.26

1.3

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

395

1.10

0.26

1.7

12.47

14.35

nmol/l

1.20

359

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

516

1.08

0.25

1.0

1.1

1.30

10.45

nmol/l

2.17

115

(3034274) Bile acid [Moles/volume] in Serum --fasting

358

0.90

0.24

1.5

1.3

6.90

14.48

umol/l

1.67

246

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.79

0.24

2.4

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

211

0.87

0.24

1.1

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

411

3110

0.97

0.24

1.1

422.60

205.47

titre

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

711

5335

0.98

0.22

1.8

2.2

3.82

3.70

g/l

1.03

574

4674

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

223

1704

0.96

0.22

1.3

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

668

5013

0.98

0.22

1.8

2.2

10.33

10.26

g/l

0.14

528

4305

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.22

0.0

1.3

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.22

0.0

6.8

—

8.88

—

(3037756) Immunofixation for Serum or Plasma

427

3051

1.03

0.22

1.4

1.5

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

442

3162

1.03

0.21

1.4

257.77

260.44

ug/g

0.10

239

1948

(3020911) Cortisol [Moles/time] in 24 hour Urine

239

0.89

0.21

1.3

75.38

185.00

nmol/24h

1.36

239

(3002385) Erythrocyte distribution width [Ratio]

10324

76069

0.99

0.20

24.7

22.0

15.05

15.61

22.56

10069

74522

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

435

3114

1.03

0.20

1.1

1.06

1.17

u/ml

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

141

1.15

0.20

1.2

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

209

1592

0.96

0.19

4.9

6.0

12.61

12.50

mg/l

0.12

179

1423

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.82

0.19

1.1

1.0

—

(3021901) Oxygen saturation in Capillary blood

366

2617

1.03

0.19

2.5

2.9

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

237

0.90

0.19

1.0

1.1

0.55

0.68

umol/24h

1.05

102

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

715

5345

0.98

0.18

1.8

2.2

—

(3025941) Bacteria identified in Stool by Culture

675

4867

1.02

0.18

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

570

0.94

0.18

1.2

9.66

9.61

mmol/l

0.03

541

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

716

5350

0.98

0.17

1.8

2.2

7.61

7.53

g/l

0.61

576

4686

(3023383) Lactate [Moles/volume] in Pleural fluid

512

1.06

0.17

1.3

4.20

3.33

mmol/l

0.97

470

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

534

3844

1.02

0.17

1.8

2.3

0.02

0.05

g/l

1.16

444

3442

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2520

18356

1.01

0.16

2.4

2.8

0.81

mmol/l

1.79

2226

16850

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

212

0.90

0.16

1.0

1.3

0.33

0.32

g/l

0.22

165

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.13

0.16

1.0

1.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.11

0.16

1.0

1.2

—

(3020491) Glucose [Moles/volume] in Blood

107

751

1.05

0.16

1.8

2.2

7.29

7.28

mmol/l

0.01

499

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.16

0.16

11.2

10.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

119

0.86

0.15

1.6

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

130

1.13

0.15

4.5

5.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

272

1.08

0.15

1.1

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.82

0.15

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.83

0.14

1.3

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

259

1.08

0.13

1.7

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

407

3046

0.98

0.13

2.5

2.9

7.45

7.77

kpa

3.45

400

2968

(46235355) HIV 1 and 2 tests - Meaningful Use set

1025

7613

0.99

0.13

1.4

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.85

0.13

1.0

—

(3001729) Color of Synovial fluid

118

1.12

0.12

1.5

1.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

498

3599

1.02

0.12

1.8

2.3

0.00

g/l

0.19

410

3213

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

889

6605

0.99

0.12

1.5

1.6

1.60

1.58

g/l

0.42

702

5597

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

162

1159

1.03

0.10

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

476

0.96

0.10

1.1

2.6

60.13

69.35

mg/l

0.65

317

(3026692) Albumin [Mass/volume] in Peritoneal fluid

277

1.06

0.10

1.6

1.4

10.33

15.25

g/l

2.70

220

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.11

0.10

1.0

1.1

—

0.09

—

(3009343) pH of Capillary blood

1071

7930

0.99

0.09

3.1

3.8

7.42

0.72

153

1043

(3023487) Leukocytes [#/volume] in Peritoneal fluid

385

0.95

0.09

1.7

1.9

352.03

4545.34

e6/l

1.08

265

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.05

0.09

1.6

1.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1047

7752

0.99

0.09

5.9

7.5

92.90

93.70

2.90

1041

7720

(1616796) Gas panel - Central venous blood

398

2963

0.99

0.09

3.3

3.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

317

0.95

0.09

1.1

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1521

11240

0.99

0.08

2.1

2.5

65.49

65.84

g/l

0.95

1265

9959

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.80

0.08

7.0

8.4

—

(4212803) Bone marrow aspirate examination

136

0.92

0.08

1.1

1.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1288

9399

1.01

0.08

2.1

2.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

256

0.95

0.08

1.1

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.80

0.07

1.0

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.12

0.07

1.0

1.1

0.83

1.11

u/field

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1086

8026

0.99

0.07

3.1

3.8

5.16

kpa

0.08

976

7536

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

486

3534

1.01

0.07

1.9

2.3

0.00

g/l

-0.00

409

3201

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

108

1.09

0.07

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.86

0.07

1.1

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

0.86

0.07

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.84

0.07

1.0

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

274

1.05

0.06

1.4

1.3

22.79

31.53

0.95

171

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

390

1.04

0.06

1.3

1.4

14.16

22.07

1.81

323

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.91

0.06

1.3

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

209

0.95

0.06

1.1

1.2

0.72

1.50

mmol/l

0.85

131

(3012501) Base excess in Blood by calculation

400

2910

1.01

0.06

4.0

4.3

2.65

2.76

mmol/l

0.33

281

1997

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

675

1.02

0.05

1.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

119

0.93

0.05

1.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

400

2912

1.01

0.05

4.0

4.4

5.02

5.00

kpa

0.22

385

2829

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2441

17979

1.00

0.05

2.1

2.5

2.18

2.25

g/l

7.22

2129

16413

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

516

1.02

0.05

3.6

2.8

216.93

217.90

u/l

0.03

508

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

274

0.96

0.04

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

125

932

0.98

0.04

2.3

1.7

314.62

302.34

mu/l

0.15

113

857

(43055442) Apixaban [Mass/volume] in Serum or Plasma

259

0.96

0.04

1.5

1.6

93.10

114.85

ug/l

0.52

217

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

481

0.98

0.04

1.3

385.46

248.09

ug/l

0.16

263

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.07

0.03

2.4

1.5

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.07

0.03

4.1

1.9

66.33

64.66

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.07

0.03

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

139

0.95

0.03

2.3

1.7

99.17

1828.06

e6/l

1.63

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

144

1047

1.01

0.02

1.3

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

271

0.98

0.02

1.1

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

330

0.98

0.02

1.4

1.6

8.33

5.43

nmol/l

0.28

282

(36660697) Celiac disease serology panel - Serum

813

5986

1.00

0.02

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

311

2273

1.00

0.02

1.5

1.6

—

(3017704) Immunofixation for Urine

105

763

1.01

0.02

1.4

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1045

7659

1.00

0.02

3.1

3.7

1.91

2.02

mmol/l

0.38

750

5668

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

672

4923

1.00

0.01

1.9

2.3

3.00

g/l

0.04

532

4261

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.94

0.01

1.0

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.06

0.01

4.5

1.8

10.67

12.23

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

288

1.02

0.01

2.5

2.4

7.09

7.70

mmol/l

0.85

196

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

130

0.96

0.01

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

400

2930

1.00

0.01

4.0

4.4

7.92

8.33

kpa

6.87

384

2847

(3033799) Differential panel - Peritoneal fluid

340

1.02

0.01

2.4

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

219

1614

1.00

0.00

1.3

1.5

—

(44786800) Granulocytes/100 leukocytes in Body fluid

225

0.98

0.00

1.3

18.79

22.97

0.27

172

(3044941) Cell count panel - Synovial fluid

239

1751

1.00

0.00

1.4

—

(3002619) Bacteria identified in Specimen by Culture

226

1.01

0.00

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

179

1317

1.00

0.00

1.3

1.5

—

(3044007) Cell count panel - Peritoneal fluid

306

1.01

0.00

1.8

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

220

1.00

0.00

1.8

1.3

—

2138155.00

—

(3011648) Oxygen content in Venous blood

107

783

1.00

0.00

1.4

1.7

10.27

10.57

0.27

107

783

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

320

1.01

0.00

1.5

2.29

1156.57

u/l

0.82

116

(3029396) Erythrocyte agglutination [Presence] in Blood

0.98

0.00

1.5

1.3

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

3.44

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

31.00

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.94

-0.00

1.0

1.3

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

1.8

—

5.67

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.0

—

0.32

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.6

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.6

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.95

-0.00

1.3

1.1

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.94

-0.00

1.8

1.5

—

(3011324) Intrinsic factor Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.00

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: G6_NEURODEG – Degenerative diseases of the nervous system

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Degenerative diseases of the nervous system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Degenerative diseases of the nervous system (G6_NEURODEG)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints